
==== Front
Int J Mol Sci
Int J Mol Sci
ijms
International Journal of Molecular Sciences
1422-0067
MDPI

10.3390/ijms23031499
ijms-23-01499
Review
Genes and Longevity of Lifespan
Bin-Jumah May Nasser 12
https://orcid.org/0000-0003-4112-0925
Nadeem Muhammad Shahid 3*
Gilani Sadaf Jamal 4
Al-Abbasi Fahad A. 3
https://orcid.org/0000-0002-1614-6456
Ullah Inam 5
https://orcid.org/0000-0003-4007-4023
Alzarea Sami I. 6
https://orcid.org/0000-0002-9179-4373
Ghoneim Mohammed M. 7
https://orcid.org/0000-0002-0922-9819
Alshehri Sultan 8
Uddin Aziz 9
Murtaza Bibi Nazia 10
https://orcid.org/0000-0003-1881-5219
Kazmi Imran 3*
Bondy Stephen C. Academic Editor
Galderisi Umberto Academic Editor
Di Bernardo Giovanni Academic Editor
1 Biology Department, College of Science, Princess Nourah Bint Abdulrahman University, Riyadh 11671, Saudi Arabia; mnbinjumah@pnu.edu.sa
2 Environment and Biomaterial Unit, Health Sciences Research Center, Princess Nourah Bint Abdulrahman University, Riyadh 11671, Saudi Arabia
3 Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia; fabbasi@kau.edu.sa
4 Department of Basic Health Sciences, Princess Nourah Bint Abdulrahman University, Riyadh 11671, Saudi Arabia; SJGlani@pnu.edu.sa
5 Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore 54000, Pakistan; inamgenetics@gmail.com
6 Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia; samisz@ju.edu.sa
7 Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Ad Diriyah 13713, Saudi Arabia; mghoneim@mcst.edu.sa
8 Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia; salshehri1@ksu.edu.sa
9 Department of Biotechnology and Genetic Engineering, Hazara University, Mansehra 21300, Pakistan; geneticsaz@gmail.com
10 Department of Zoology, Abbottabad University of Science and Technology (AUST), Abbottabad 22310, Pakistan; nazia.murtaza@gmail.com
* Correspondence: mhalim@kau.edu.sa (M.S.N.); ikazmi@kau.edu.sa (I.K.)
28 1 2022
2 2022
23 3 149905 12 2021
26 1 2022
© 2022 by the authors.
2022
https://creativecommons.org/licenses/by/4.0/ Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Aging is a complex process indicated by low energy levels, declined physiological activity, stress induced loss of homeostasis leading to the risk of diseases and mortality. Recent developments in medical sciences and an increased availability of nutritional requirements has significantly increased the average human lifespan worldwide. Several environmental and physiological factors contribute to the aging process. However, about 40% human life expectancy is inherited among generations, many lifespan associated genes, genetic mechanisms and pathways have been demonstrated during last decades. In the present review, we have evaluated many human genes and their non-human orthologs established for their role in the regulation of lifespan. The study has included more than fifty genes reported in the literature for their contributions to the longevity of life. Intact genomic DNA is essential for the life activities at the level of cell, tissue, and organ. Nucleic acids are vulnerable to oxidative stress, chemotherapies, and exposure to radiations. Efficient DNA repair mechanisms are essential for the maintenance of genomic integrity, damaged DNA is not replicated and transferred to next generations rather the presence of deleterious DNA initiates signaling cascades leading to the cell cycle arrest or apoptosis. DNA modifications, DNA methylation, histone methylation, histone acetylation and DNA damage can eventually lead towards apoptosis. The importance of calorie restriction therapy in the extension of lifespan has also been discussed. The role of pathways involved in the regulation of lifespan such as DAF-16/FOXO (forkhead box protein O1), TOR and JNK pathways has also been particularized. The study provides an updated account of genetic factors associated with the extended lifespan and their interactive contributory role with cellular pathways.

aging
life expectancy
genes
genetics
DNA damage repair
signaling pathways
==== Body
pmc1. Introduction

Aging is a multifaceted, complex process represented by the functional decline of tissues and organs due to changes in molecular composition and physiology of cells. An increase in the human lifespan has been reported for last many decades [1]. According to the estimates of United Nations, there were more than 63 million people above 90 years of age in 2020 [2]. Longevity of human life is heritable from 20% to 40% in the modern human populations [3]. Survival into extremely long ages is a characteristic clustered in families [4]. Better immune systems, metabolic health such as enhanced insulin sensitivity [5], lipid metabolism leading to healthy levels of plasma lipids [6], and delay or ability to avoid age related diseases has also been observed in the longevous families [7,8]. As longevity of life exhibits high heritability, insights into the genetic factors may improve our present understanding of mechanisms responsible to promote health and reduce the risk of diseases [3,9]. However, a few genes and genetic loci have been identified for this trait in the recent studies [10,11,12]. Gene coding for apolipoprotein (APOE) has been reported by multiple genome-wide association studies (GWAS) [10,11,12]. Telomeres are the protective caps at the termini of human and other eukaryotic chromosomes. Their length decreases with age, though it is dependent on many internal and environmental factors. According to reports based on experimental models, the overall length or rate of telomere shortening has been reported to have a link with age expectancy [13]. The shortening of telomere length is rapid in men as compared to women, leading to a comparatively high longevity in women [14]. The application of the well-known antioxidant red wine has been reported to promote the age longevity related genes. Overall, 115 aging associated genes have been studied among 25 mammalian species [15]. Studies on the controlled human populations have shown an increase in the expression levels of Sirt1, catalase, p53 and manganese-superoxide dismutase, after 14 days of red wine use, with no serious side effects. Further studies on Drosophila melanogaster have shown up to 7% increase in lifespan after moderate red wine applications [16]. There are several other genes, such as the kinase signaling gene MAP3K5 [17], and variants of genes in the insulin/IGF1 pathway [18]. Studies on bats have shown that DNA methylation is negatively linked with longevity of lifespan, and that DNA damage is positively linked with it [19,20]. Studies on monkeys have shown that the genome flexibility and environmental adaptations also contribute to the lifespan [21]. In context with the above information, we aimed to conduct a systematic review of human genes and their non-human orthologs associated with the life expectancy.

2. Genes and Longevity of Lifespan

During past three- or four-decades, genetic researchers have identified many genes that promote lifespan in different species [22,23,24]. Some examples of candidate genes and their orthologs reported for their association with longevity of lifespan have been tabulated in Table 1.

2.1. Aging and Genomic Modulation

2.1.1. Apolipoprotein E (APOE)

APOE gene codes for a protein known as apolipoprotein E that binds with the lipid molecules to make lipoproteins. APOE is a pleotropic gene contributing to packing and transport of fats and cholesterol along with human blood, maintenance of normal blood glucose levels in the human body, neuronal cell homeostasis, adrenal and brain physiology and cardiovascular health [229]. There are three extensively studied alleles of the APOE gene, i.e., e2, e3 and e4 coding for Apo E2, E3 and E4 proteins [230,231]. Minor variations of specific amino acids give rise to binding variability in ApoE proteins for multiple corresponding molecules including LDLRs (LDL receptors), HSPGs (cell-surface heparin sulfate proteoglycans), and ABCA1 (ATP-binding cassette protein 1). The amino acid variations also affect protein stability and protein folding [232,233]. About 50% of the world’s population has e3 genotype [234]. APOE is one of the well demonstrated genes that have been clearly linked with human mortality. Studies on European populations have shown up to 3.5% contribution of APOE gene in human lifespan [235]. There are consistent studies demonstrating the role of allele e4 in the onset of Alzheimer disease and cardiovascular health [236,237]. Approximately a 4.2 year shorter lifespan has been found among the populations having high frequency of e4 allele [238]. In a series of experiments Finch, Sapolsky, and Stanford have shown that an interaction between diet and genotype play an important role in the longevity of human lifespan [239,240,241]. They also emphasized that the carriers of e4 alleles have higher cholesterol levels with greater chances of plaque formation in the arteries and enhanced risk of cardiovascular diseases, dementia, stroke and Alzheimer’s disease [230]. There are many factors that contribute to the longevity of lifespan in association with genotypes. Aerobic exercise improves the longevity of human lifespan among e4 allele carriers [242]. The impact of diabetes on the human lifespan is also genotype dependent [243]. There is evidence that the increase in human lifespan started about 1.8 million years ago, at those times the human populations were likely to be homozygous for the e4 allele [244]. Based on several studies, a relationship between cognitive decline and e4 genotype [245], high mortality rate due to pneumonia and severe dementia have been reported in old men with e4 genotype [246]. The e4 type have been reported to have short telomeres that have a role in life expectancy [247]. In Japanese and Italian populations, e2 allele is found to favor and e4 allele decrease the chances of exceptional longevity of lifespan [248]. The main hurdle in the development of ApoE based therapeutics is due to limited understanding of each ApoE (subtype) mediated pathway and its impacts on overall human physiology [25].

2.1.2. p53

p53 is a gene that codes for cell cycle regulatory protein responsible to maintain the genome stability, reduce the mutation rate and suppress cancer. Human tumors have been frequently linked with p53 mutations; about 50% of all tumors involve disruption of this gene [249,250]. The presence of the p53 gene in short lived organisms such as worms and flies, who do not develop cancers, indicate that tumor suppression is not the only function of p53 gene. According to recent studies, p53 and p73 play crucial roles in reproduction [251,252]. There is strong evidence that p53 has the complex role in the regulation of longevity of life in mice, flies, Caenorhabditis elegans, and humans [253,254,255], both longevity of lifespan and maturity age for reproduction are always coupled. A short form of p53 also known as p44 has been found associated with the body size and lifespan in mice. Regulated expression of p53 isoforms is responsible to maintain a balance between tissue regeneration and tumor suppression in mammals [256]. DNA damage is considered one of the main reasons behind short lifespan, p53 gene is responsible to maintain the integrity of DNA in species. In the genome of elephants 12 to 20 copies of p53 gene have been reported that are meant to reduce the chances of cancer and DNA damage [257]. (Role of p53 in the regulation of cell division or apoptosis under damaged or mutated conditions is described in the DNA repair section.

2.1.3. Sirtuin (SIRT1)

Sirtuin (SIRT) is considered an important factor to extend the longevity of lifespan by delaying cellular senescence [258]. SIRT1 is an important member of an NAD+ dependent family of enzymes that have multiple roles in the cells including cell cycle regulation, regulation of energy metabolism, gene silencing and gene regulation [259]. SIRT1 responsible for the deacetylation of tumor suppressor p53 protein, NF-κB and Ku70 (DNA repair factor), is the most well studied isozyme SIRT [260,261,262]. It also regulates FOXO family of transcription factors and STAT3 (signal transducer and activator of transcription 3) [263]. Sirtuin improves the cellular ability to sustain genome integrity by promoting the DNA repair process. It can enhance the ability of a cellular system and makes it resistant the oxidative stress [264]. Increased levels of sirtuin (SIRT2 and SIRT6) have shown prolongevity effect in Drosophila melanogaster, Saccharomyces cerevisiae, Caenorhabditis elegans, and mice [225,265,266]. Overexpression of brain-specific Sirt1 in transgenic mice prolonged their median lifespan by 9% in males and 16% in females [267]. The cellular levels of nicotinamide adenine dinucleotide (NAD+), a “cozymase” can promote DNA repair by reducing metabolic stress and improving mitochondrial function. An increased level of NAD+ in the mammalian and mice cells have shown an activation of SIRT1 and SIRT3 resulting in an increased oxidative metabolism eventually protecting against high fat diet induced problems [268]. The supplementation of precursor molecule of NAD+, NMN (nicotinamide mononucleotide) can reduce the DNA damage, heart failure, and effects of acute renal injury in a SIRT1-dependent manner [269,270]. NMN can help to maintain telomere length, decreases adipogenesis, and improves the osteogenesis in aged mice via SIRT1 activation [271,272]. Administration of NMN has reportedly increased the lifespan in aged mice via (PARP1)/SIRT1 axis [273]. SIRT1 activation reduce insulin resistance, enhances insulin sensitivity via PGC1-α (PPARγ co-activator 1α), implementing beneficial effects in obesity and diabetes type 2 [274,275]. Insulin sensitivity is enhanced by SIRT1 activation via reduction in the expression of proinflammatory genes and it attenuates the insulin resistance induced by tumor necrosis factor alpha (TNF-α) [259,276]. SIRT1 inhibits the production of proinflammatory cytokines via NF-kB [277], and STAT3 [278]. It also exhibits anti-apoptosis activity through p53 and FOXO regulation [279,280,281]. Activation of Sirt1 inhibits lipogenesis and promotes fatty acid β-oxidation [15,282,283] (Figure 1).

3. Genomic Instability and Oxidative Stress in Longevity of Lifespan

It has been a universal goal to understand the events and adopt the measures to slow down, stop or reverse the aging process [284]. The most important DNA modification associated with aging is DNA methylation. DNA methylation based biomarkers have answered many of the questions about the aging process and have described the role of epigenetics. As epigenetic changes in the human body are reversible, these biomarkers are therefore useful for the identification and validation of anti-aging interventions [285]. DNA methylation has been linked with human age and the aging process in man and other species. Measurement of changes in methylation (decrease/increase) at a few hundred specific CpG sites can estimate chronological age and mortality [286,287]. Studies have shown that an increased difference between chronological age and DNA methylation age is positively associated with chances of mortality [288,289,290]. Studies by Hannum and Horvath have shown that a difference of 5 years between these two age types can increase the chances of mortality by 11% to 21% [286,287]. An accelerated DNA methylation age significantly increases the risk of can, stroke and cardiovascular diseases [291,292]. The second genetic factor associated with aging is histone modifications. Alterations (decrease/increase) in the methylation of histones have been reported to regulate aging process in C. elegans [293]. High levels of trimethylation of H3K4 reduces lifespan of C. elegans [294]. Histone methylations have been linked with cellular pathways regulating the age and lifespan. The process of autophagy slows down with age, due to decrease in the ratio of cellular functional mitochondria and subsequent increase in the ROS, aggregation of insoluble or exhausted proteins in the cells. In such cases, avoiding the decrease in autophagy results in the extension of lifespan [295]. Another consequence of the aging process is accumulation of damaged DNA (mutated, irreparable, double stranded breaks) due to decreased efficiency of damaged DNA repair system (DDR system) in the old cells. Histone methylation promotes the DDR of cells and improve the life activity [296]. Acetylation of histones catalyzed mostly by NAD-dependent acetyltransferases is the third important genetic factor associated with the extension of lifespan. Histones are well established role in DNA packaging and regulation of gene expression [297]. Histone modifications are not only associated with rate of transcription but also regulate the precision of transcription process [298]. Acetylated histones are readily available to interact with transcription factors resulting in high levels of transcription [299]. Age associated decrease in histone acetylation is basis of decline in rate of transcription and metabolism leading to shortening of lifespan [300,301].

At present, the calorie restriction (CR) and calorie restriction mimetics such as rapamycin have been used as interventions to reduce the difference of methylation based age and chronological age [302]. CR interferes the DNA methylation by activation of DNA methyltransferase, resulting in hypermethylation and silencing of Ras and p16INK4a genes, both of these genes are associated with senescence [303,304]. CR presents an important anti-aging therapy to increase the lifespan of humans, non-human primates and rodents [305,306] (Figure 2).

Another critical factor associated with the survival of a cell is the maintenance of genomic DNA in its intact form. Damaged or mutated DNA accumulation in the multicellular organisms often leads to the onset of cancer or triggers the aging process [307,308,309]. DNA damage triggers aging process by blocking transcription, activating the signal transduction processes, regulating the DNA metabolism, altering the epigenome and finally by inducing apoptosis [310,311,312]. Normally, the DNA damage is recognized by genomic DNA followed by the induction of DNA repair mechanisms such as BER (base excision repair), and double standard breaks (DSBs). If the DNA damage signals continue, the cells select to avoid the replication of mutated or damaged genome rather they prefer to promote the processes leading cell cycle arrest of apoptosis [313,314]. Signaling cascades by the detection of damaged DNA are initiated by the activation of MRN (MRE11/RAD50/NBS1) complex subsequent activation of PIKKs (phosphatidylinositol 3-kinase-like kinases) ATM (ataxia-telangiectasia mutated), ATR (ATM-related kinase) [315,316,317]. ATM and ATR are activated by DNA DSBs and stalled replication forks respectively. Both of these activated factors operate in coordination with 53BP1 MDC1, TOPBP1, and BRCA1 that are sensor proteins responsible to bind the damaged DNA sites and for the recognition of DDR along [318]. TOPBP1 plays a critical role to preserve genome integrity during mitosis [319,320]. After the DNA damage recognition, the transducer kinase check points are phosphorylated and activated such as CHK2 (checkpoint kinase 1) and CHK1 (checkpoint kinase 1), followed by the activation of p53 [321,322] (major roles of p53 in the cellular physiology have already been described in the previous sections). Failure of proper DNA repair mechanism or in case of irreversible DNA damage, the cascades towards programmed cell death are initiated. Activated p53 is recognized as the master regulator of cell cycle, aging, apoptosis. P53 is required for cellular degeneration by genomic DNA damage not required for mitochondrial DNA damage response [323]. In fact a balance of antioxidant and prooxidant activities by p53 in response to oxidative stress play an important role in the longevity of lifespan [324] (Figure 3).

Oxidative stress typically caused by reactive oxygen species (ROS), ultra-violet and ionizing radiations can damage cellular components, especially the lipids, proteins and DNA [325]. Genomic instability includes the events leading to permanent or temporary changes in the genome such as duplications, deletions, inversions and translocations in the chromosomes [326]. Genomic instability may lead to changes in the gene expression, enhance the changes of apoptosis, and it is known as a hall-mark of cancer initiation, age related neurodegenerative diseases [327,328,329]. In the human body, number and diversity of lymphocytes is regulated by the repeated hexanucleotides (TTAGGG) n of 10 kb to 15 kb length known as telomeres [330]. Shortening of telomeres stops the cell division and production of lymphocytes leading to subsequent loss of cellular ability in immune response [331].

Circadian rhythms also play important role in the mammalian cell biochemistry and physiology. Almost each cell has a mechanism to respond to the day night cycles which are mainly regulated by hypothalamus area of brain which is a master pacemaker to modulate cell signaling according to the photoperiods. The circadian desynchrony may lead to the neurodegenerative disorders and metabolic pathologies that ultimately impact the lifespan [332]. The aging process and longevity of lifespan has many well established risk factors including diabetes, obesity, problems of cardiovascular system due to the lack of physical activity. Several epigenetic factors also contribute to the longevity of lifespan [333].

4. DAF-16/FOXO (Forkhead Box Protein O1), TOR and JNK Pathways in Aging

DAF-16/FOXO (Forkhead Box Protein O1), TOR and JNK Pathways

DAF-16 is an orthologous gene coding for FoxO (fork head box transcription factors class O) that regulates the expression levels of genes associated with stress metabolism, aging development and immunity [334,335,336]. There are 19 subclasses of FOX transcription factor in mammals and 6 of them are found in humans [337]. DAF-16 activity is regulated by insulin/ IGF-1 (insulin like-growth factor 1) via IIS (insulin/IGF-1 signaling) pathway [338]. IIS cascade is triggered by the binding of insulin such as peptides (ILPs) to a tyrosine kinase receptor. There are 40 different types of ILPs in Caenorhabditis elegans and 10 members of ILPs are found in the human body. IGF-1 and IGF-2 behave similar to those found in C. elegans and interact with tyrosine kinase receptor [57,339,340]. These two transcription factors (DAF-16/FOXO and HLH-30) are co-expressed in most of the human tissues particularly in the neuron and intestinal cells [341,342]. For its activity, DAF-16/FOXO directly binds with HLH-30 (helix-loop-helix transcription factor HLH-30) to make a complex to two transcription factors, this binding is conserved in human [343,344]. Activation of DAF-16/FOXO by low IIS triggers the complex formation. DAF-16/FOXO is translocated to the nucleus, this action is mediated by HLH-30 under longevity promoting conditions. Both factors require each other for their action and participate in the coregulation of hundreds of genes associated with the longevity of lifespan [32,345]. The transcription factors DAF-16/FOXO and HLH-30 are not only associated with longevity of life but also play an important role in the stress resistance [346].

DAF-16/FOXO acts as a joining point for different signaling pathways leading to longevity of lifespan and management of stress. IIS is the basic pathway, highly conserved from C. elegans, Drosophila melanogaster and mammals [283,347,348]. A signaling cascade initiated by the interaction of insulin such as peptides (ILPs) to the insulin / IGF1 receptor known as (DAF2) results in the downstream activation or regulation of IRS (insulin receptor substrate), P13K (phosphoinositide 3-kinases), PDK (3-phosphoadenosine kinase), and AKT or PKB (protein kinase B), resulting in the inhibition of FOXO. The main consequences of this cascade include the promotion of glucose transport, protein synthesis, cell proliferation, cell differentiation, and inhibition of apoptosis that enhance the longevity. Any stressed conditions or food restrictions leading to the obstruction of IIS signaling pathway will subsequently enhance the DAF-16/FOXO transcriptional activity, regulation of downstream genes resulting to manage stress and increase in the longevity of lifespan (Figure 4).

Target of rapamycin (TOR) kinase which occurs in two distinct forms (TORC1 and TORC2) coded by the same gene. TOR participates to interact between the nutrients and growth promoting (anabolic) metabolic signals [349,350]. TOR pathway is activated by the presence of ample amounts of ATP, oxygen, and amino acids, it triggers the synthesis of nucleotides, lipids, promotes the levels of messenger RNAs and their subsequent translation [351]. TOR signaling is generally responsible for growth and development. However, it has also been linked with aging and diseases such as cancers, cardiovascular diseases, diabetes and neurodegenerative diseases [352,353]. Inhibition of TOR pathway can promote longevity by reducing mRNA translation [354,355,356]. Reduction in the protein synthesis reduces the overall burden on the cellular resources and machinery, it also promotes the expression of genes associated with cell protection. Genetic interference to inhibit the translation process has been linked with the longevity of life in C. elegans, the process has been associated with the inhibition of TOR pathway [357,358]. Transcription factor SKN1 (skinhead-1) and DAF-16 genes play an important role in the protection of cells by reducing translation. The similarity in their action suggests the regulation of these transcription factors by TOR pathway [359,360]. Reduced or inhibited TORC1 activity triggers SKN-1/Nrf and DAF-16/FoxO regulated reduction in the stress levels and increased lifespan [360]. The role of SKN-1 is interesting as it is considered as less important transcription factor to DAF-16. IIS inhibits both SKN-1 and DAF-16 by phosphorylation and translocation to the nucleus. However, TORC1 affects the SKN-1 present in the nucleus. A considerable number of SKN-1 molecules are found to occupy specific promoter sites under the conditions without significant stress [361]. Many isoforms of DAF-16 are accumulated in the nucleus when IIS is reduced [36,322,362], but only a single isoform DAF-16f is translocated to the nuclei by the inhibition of TORC1 indicating the most important isoform associated with longevity of life [36]. It has been reported that TORC1 and IIS influence DAF-16/FOXO and SKN1 by different mechanisms. In case of TORC1 induces longevity of life, SKN-1/Nrf are required and presence of DAF-16/FOXO is not obligatory [360] (Figure 4). Under heat stress conditions, JNK-1(Jun N-terminal kinase 1) also indorses the movement of DAF-16 into nucleus, it also facilitates the removal of binding partner 14-3-3 protein by phosphorylation [363,364]. In mammalian cells the FOXO4 can be directly phosphorylated, and its activity can be enhanced by JNK [365]. In mammals, the components of JNK also interact with insulin receptor substrate 1 (IRS-1). According to the reports JNK phosphorylated and inhibited IRS-1 and activated AKT1 [366] (Figure 4).

The well-known signaling pathways based on the NF-κB system that are associated with the human immune system are activated during aging. As the DNA damage in increased by the increased oxidative stress with age, it promotes the activity of NF-κB system that leads to adverse effects such as increase in apoptotic resistance, decrease in autophagy, and an enhanced inflammatory response. A number of inhibitors of NF-κB system are considered as longevity factors [367]. Nuclear receptors are also known to play an important role in the aging process. The NR4A subfamily of orphan nuclear receptors acts as nutrient sensors and promotes biogenesis, improves mitochondrial functioning, and contributes to DNA damage repair. These receptors are considered potential targets to slow down the aging process [368]. Nuclear receptor Nurr1 regulates the development of the dopaminergic phenotype from neuronal precursors. According to recent reports, a decrease in the Nurr1 expression leads to an enhanced inflammatory response resulting in the death of dopaminergic neurons. Hemizygosity of Nurr1 is necessary to protect against Parkinson’s disease [369].

5. Conclusions

The lifespan of living organisms is highly flexible and vulnerable to internal physiological factors and environmental conditions that govern the epigenetics. Expression and suppression levels of tens and hundreds of genes have been considered to play a significant contribution to the expected longevity of life. We have tabulated fifty such genes and a few have been elaborated for their influence in the regulation of aging process and lifespan. In addition to the contribution by gene expression regulatory systems, there is sufficient data with diverse evidence to support the critical role of DNA damage in the longevity of lifespan. The integrity of genomic DNA is an obligatory condition to maintain the cellular physiology and continuation of its transfer to the next generations from cell to organism levels. However, DNA is highly vulnerable to the internal and external stress conditions and chemical interferences. DNA modifications such as DNA methylation, acetylation of histones and physical damage to the DNA play important in the aging process and often lead to the unexpected outcomes in the lifespan. The efficient recovery of damaged DNA is crucial to the successful replication and inheritance of genome to the next generations. Failure to the proper DNA damage repair often leads to cell cycle arrest, apoptosis or cell death. The lifespan associated pathways regulate growth, essential physiology and reproduction of organisms. However, under adverse conditions, these pathways shift to protective and stress-bearing modes, eventually leading to an extended lifespan.

6. Future Perspective

Currently, research on the contribution of genes to the aging process, cellular stability, and longevity of lifespan is at initial stages. The data available is scattered, and the individual reports provide information about the contribution of selected either a gene or a group of similar genes and genetic mechanisms in the regulation of aging and lifespan, i.e., different reports are available representing the genes responsible for extended lifespan in humans, C. elegans and Drosophila. Genes regulating the cell cycle, apoptosis, managing the adverse effects of oxidative stress, and their association with life-threatening pathologies such as CVDs, diabetes, and neurodegenerative conditions have been reported but the mechanisms involved mostly remain unclear in the available reports. Large-scale genome-wide association studies (GWAS) in association with epigenetic approaches are required to demonstrate the coordination between different genes, their regulatory factors in the aging process and to reveal the mechanisms. Further studies for the identification of potential genetic targets to protect against aging-associated diseases are also required. Finally, the translation of these genetic findings into clinical practice poses a big challenge.

Author Contributions

Conceptualization, M.S.N., B.N.M., M.N.B.-J. and I.K.; writing—original draft preparation, M.S.N. and I.U.; writing—review and editing, critical revision, M.N.B.-J., S.J.G., F.A.A.-A., M.M.G., S.I.A., A.U. and S.A. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

Figure 1 Regulatory role of SRT1 signaling in the cell. SIRT1, an NAD-dependent deacetylase affects several downstream molecules and promotes life. Sirt1 based downregulation of apoptosis and inflammation leads to the extension of lifespan contrary to that enhanced lipid metabolism and insulin sensitivity are main factors that increase the lifespan. As the discussion included the sirt1 gene and we have a separate section for the associated pathways, Figure 1 was meant to indicate the central role of sirt1 gene in the cellular and metabolic pathways involved in the extended lifespan. Green colour indicates final process regulated, downward and upward arrows indicate downregulation and upregulation of process.

Figure 2 Proposed mechanistic role of DNA methylation, histone methylation and histone acetylation in the regulation of lifespan in the human and other species. Upward and downward arrows indicate upregulation and downregulation of specific genes of processes. Some major aspects have been highlighted by specific colours.

Figure 3 Role of DNA damage repair system in the longevity of lifespan. Successful DNA repair leads to the continuation of life activity/cell division, contrary to that failure in the DNA repair promotes programmed cell death (apoptosis). Direction of arrows indicate upregulation or downregulation of a process.

Figure 4 Longevity of lifespan regulated by IIS pathway via DAF-16/FOXO, TOR pathway vis SKN1/Nrf and FOXO regulation, and by JNK under oxidative stress by phosphorylation and inactivation of IRS1 and activation of AKT.

ijms-23-01499-t001_Table 1 Table 1 Human genes and their orthologues associated with the longevity of lifespan. The main physiological roles of and reported association with life threatening diseases have been discussed for each gene.

Sr. No.	Gene	Protein	Main Physiological Role	Change with Age or Abnormility	Reference	
1	APOE	Apolipoprotein E	Odulation of cholesterol balance

Aggregability of platelets

Proliferation of lymphocytes

	Pathogenesis of atherosclerosis and in Alzheimer’s disease	[25,26,27]	
2	P53	Tumor protein p53	Tumor suppression

Transcription activation

	Cancer	[28,29,30]	
3	SIRT1	Sirtuin 1 protein	Metabolism and energy homeostasis

DNA damage response

	Aging, cancer
Slow lipid metabolism	[31,32,33,34,35]	
4	DAF-16	FOXO1 transcription factor	Transcription factor

	Cell cycle arrest, apoptosis	[36,37,38]	
5	CHRNA3	Cholinergic receptor nicotinic alpha 3 subunit	Response to foreign materials such as nicotine and alcohol

Nervous system

	Addiction to alcohol/cocaine
Decline in nerve response	[39,40]	
6	SH2B3	SH2B adaptor protein 3	Multifunctional adopter protein

	Cancer, age dependent Insulin resistance	[41,42,43,44,45]	
7	CDKN2A	Cyclin dependent kinase inhibitor 2A	Cell cycle control

	Diabetes type 2, obesity, adipose tissue browning, cardiac dystrophy	[46,47,48,49,50,51]	
8	ELOVL2	Elongation of very-long-chain fatty acids-like 2	DHA (Docosahexaenoic acid) synthesis, lipid storage

	Glucolipotoxicity-induced apoptosis	[52,53,54,55]	
9	WRN	Werner protein	DNA protection against oxidative stress damage, genome stability

	Premature aging disease, cataracts, atherosclerosis, osteoporosis, and cancer	[56,57,58,59,60]	
10	PON1	Paraoxonase 1	Detoxifies Hcy-thiolactone in human blood and reduces chances of atherosclerosis

	Cardiovascular disease	[61,62,63,64]	
11	SOD2	Superoxide dismutase 2	Fights against oxidative stress

ROS scavenger

	Alzeimer’s disease, diabetes, cardiac complications	[65,66,67,68]	
12	LMNA	Lamin A protein	Regulation of antioxidant associated genes,

Impaired protein dysregulation

Cardiomyocites function

	Accelerated aging process	[69,70,71,72]	
13	CETP	Cholesteryl ester transfer protein	Lipoprotein metabolism

	Cardiovascular diseases	[73,74,75,76]	
14	APOC3	Apolipoprotein C3	Lipid transport

Glucose metabolism

Neuronal signaling

	Insulin resistance
Coronary artery calcium and AD	[77,78,79,80]	
15	MTP	Microsomal triglyceride transfer protein	Multifunctional protein,

cholesterol synthesis,

lipd transport

lipid and lipoprotein homeostasis

	Metabolic diseases	[81,82,83]	
16	PIK3CA	Phosphatidylinositol 3-kinase (PI3K).	Neuronal differentiation and survival

	Cancer	[84,85,86,87]	
17	DAF-2	Insulin-like growth factor 1 (IGF-1) receptor	Anabolic and mitogenic activity

	Cancer	[88,89,90,91]	
18	PIMT	Protein-L-isoaspartyl methyltransferase	Intrecellular signal transduction

	Fatal epilepsy	[92,93,94]	
19	GH1	Growth hormone	Growth and development

Interaction with insulin-like growth factor

	Aging
Chronic kidney disease	[95,96,97,98,99,100]	
20	KLOTHO	Protein alpha-klotho	Aging suppression

Organ protection

Phosphate homeostasis

Vascular physiology

	Chronic kidney and vascular disease,	[101,102,103,104,105,106,107,108]	
21	CREB	cAMP-response element binding protein	Neuronal protection, plasticity and memory

Triglyceride metabolism

	Alzheimer’s disease	[109,110,111,112,113]	
22	MAPK	Mitogen-activated protein kinase	Multiple physiological functions

Innate immune response

Stress signaling

	Alzheimer’s disease
Parkinson’s disease
Cardiac hypertrophy	[114,115,116,117,118,119]	
23	EGFR	epidermal growth factor receptor	Nervous system physiology

Actin remodeling in sperm capacitation

	Cancer	[120,121,122,123,124]	
24	NF-kB	Nuclear factor kappa B	Immune response modulator/activator

Depression

	Coronary artery disease
Cancer and immune diseases	[125,126,127,128,129,130]	
25	PLC-β	Phospholipase C beta	Signal transduction

Brain activity

Breast cancer suppression

	Neurodegenerative disease; metastasis	[131,132,133,134]	
26	MSR-A	Methionine sulfoxide reductase A	Repair of of oxidized methionine in proteins

Protects against oxidative stress

	Neurodegenerative diseases, cystic fibrosis, neurological disorders, cancer	[135,136,137,138]	
27	MEMO1	Mediator of cell motility 1	Cell migration (neuronal cells),

Organismal development

Central nervous system

	Cancer
Neurological disorders	[139,140]	
28	NEIL1	Nei like DNA Ggycosylase 1	Neurogenesis

DNA repair

Neuronal protection against oxidative stress

	Alzheimer’s disease	[141,142,143]	
29	PPARγ2	Peroxisome proliferator-activated receptor gamma 2	Adipogenesis

Lipid metabolism

	Cardiovascular diseases	[144,145,146,147]	
30	EIF3K	Eukaryotic translation initiation factor 3 subunit K	Regulation of apoptosis in C. elegans

	Lifespan extension in C. elegans	[148,149,150]	
31	ATM	ATM serine/threonine kinase	Cellular response to genotoxic stress

	Lymphoid malignancies
Coronary artery disease	[151,152,153,154]	
32	BCL2	B-cell lymphoma 2	Multiple functions

neuronal activity

autophagy

calcium homeostasis

	Huntington’s disease
Chronic obstructive pulmonary disease	[155,156,157]	
33	CDC42	Cell division cycle 42	Regulation of mammary gland functioning

	Genomic instability
Aging	[158,159,160,161,162]	
34	DGAT1	Diacylglycerol O -acyltransferase 1	Triglyceride metabolism

Promote LDL levels

	Congenital diarrheal disorder	[163,164,165,166]	
35	EGR1	Early growth response 1	Complex response to stress

	Cancer	[167,168,169,170]	
36	FGF23	Fibroblast growth factor 23	Phosphate and vitamin D metabolism

	Chronic kidney disease	[171,172,173]	
37	FGF21	Fibroblast growth factor 21	lipolysis in adipose tissue

	Cardiovascular disease	[174,175,176,177,178]	
38	FN3KRP	Fructosamine 3 kinase related protein	Cell maintenance and viability

Longevity of lifespan

	-	[179,180]	
39	PGP	Phosphoglycolate phosphatase	Intermediary metabolism

	Cardiometabolic diseases	[179,180,181]	
40	IRS1	Insulin receptor substrate 1	Insulin signaling

	Coronary artery disease
Tau pathology in alzheimer’s disease	[182,183,184,185,186]	
41	BMI1	Polycomb complex protein BMI-1	Gene silencing

Regulation of chromatin structure

Cellular bioenergetics

DNA damage response

	Hematologic malignancies	[187,188,189,190,191]	
42	NRG-1	Neuregulin 1	Signaling in the cardiovascular system

Maintenance of muscle spindles

	Schizophrenia	[192,193,194,195,196]	
43	STAT	Signal transducer and activator of transcription	Multiple roles

Cell signaling

	Autoimmune diseases
Cancers	[197,198,199,200,201]	
44	E2F1	E2F Transcription Factor 1	Innate immune response

Regulation of metabolism

	Cancers	[202,203,204,205,206]	
45	VEGF-A	Vascular endothelial growth factor A	Cell signale transduction

	Cancers	[207,208,209]	
46	XME	Xenobiotic metabolizing enzymes	Breakdown of xenobiotic substances

	-	[210,211,212,213]	
47	MYC	Myc proto-oncogene protein	Maintains regular physiology

Tissue repair

Placenta development

Immune response

	Cancer	[214,215,216,217]	
48	CXCR4	C-X-C chemokine receptor type 4	Bone marrow physiology

	Cancer	[218,219,220]	
49	SIR-2	Silent information regulator 2	Extends lifespan in Drosophila

Human cardiac contractile

Suppress neurodegeneration

	Neurodegenerative disease
Cardiac failure	[221,222,223,224,225]	
50	ERK	Extracellular signal-regulated kinase	Cell signaling

	Leukemia	[226,227]	
51	SLC31		Copper transporters

	Immune dysfunction
Multiple diseases	[228]	

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Vaupel J.W. Villavicencio F. Bergeron-Boucher M.-P. Demographic perspectives on the rise of longevity Proc. Natl. Acad. Sci. USA 2021 118 e2019536118 10.1073/pnas.2019536118 33571137
2. Liu X. Song Z. Li Y. Yao Y. Fang M. Bai C. An P. Chen H. Chen Z. Tang B. Integrated genetic analyses revealed novel human longevity loci and reduced risks of multiple diseases in a cohort study of 15,651 Chinese individuals Aging Cell 2021 20 e13323 10.1111/acel.13323 33657282
3. Van den Berg N. Rodríguez-Girondo M. van Dijk I. Mourits R. Mandemakers K. Janssens A. Beekman M. Smith K. Slagboom P. Longevity defined as top 10% survivors and beyond is transmitted as a quantitative genetic trait Nat Commun. 2019 10 35 10.1038/s41467-018-07925-0 30617297
4. Pedersen J.K. Elo I.T. Schupf N. Perls T.T. Stallard E. Yashin A.I. Christensen K. The survival of spouses marrying into longevity-enriched families J. Gerontol. Ser. A Biomed. Sci. Med. Sci. 2017 72 109 114 10.1093/gerona/glw159
5. Wijsman C.A. Rozing M.P. Streefland T.C. le Cessie S. Mooijaart S.P. Slagboom P.E. Westendorp R.G. Pijl H. van Heemst D. Leiden Longevity Study Group Familial longevity is marked by enhanced insulin sensitivity Aging Cell 2011 10 114 121 10.1111/j.1474-9726.2010.00650.x 21070591
6. Vaarhorst A.A. Beekman M. Suchiman E.H. Van Heemst D. Houwing-Duistermaat J.J. Westendorp R.G. Slagboom P.E. Heijmans B.T. Lipid metabolism in long-lived families: The Leiden Longevity Study Age 2011 33 219 227 10.1007/s11357-010-9172-6 20811950
7. Andersen S.L. Sebastiani P. Dworkis D.A. Feldman L. Perls T.T. Health span approximates life span among many supercentenarians: Compression of morbidity at the approximate limit of life span J. Gerontol. Ser. A Biomed. Sci. Med. Sci. 2012 67 395 405 10.1093/gerona/glr223
8. Ash A.S. Kroll-Desrosiers A.R. Hoaglin D.C. Christensen K. Fang H. Perls T.T. Are members of long-lived families healthier than their equally long-lived peers? Evidence from the long life family study J. Gerontol. Ser. A Biomed. Sci. Med. Sci. 2015 70 971 976 10.1093/gerona/glv015
9. Slagboom P.E. van den Berg N. Deelen J. Phenome and genome based studies into human ageing and longevity: An overview Biochim. Biophys. Acta (BBA)—Mol. Basis Dis. 2018 1864 2742 2751 10.1016/j.bbadis.2017.09.017
10. Deelen J. Evans D.S. Arking D.E. Tesi N. Nygaard M. Liu X. Wojczynski M.K. Biggs M.L. van Der Spek A. Atzmon G. A meta-analysis of genome-wide association studies identifies multiple longevity genes Nat. Commun. 2019 10 3669 10.1038/s41467-019-11558-2 31413261
11. Joshi P.K. Pirastu N. Kentistou K.A. Fischer K. Hofer E. Schraut K.E. Clark D.W. Nutile T. Barnes C.L. Timmers P.R. Genome-wide meta-analysis associates HLA-DQA1/DRB1 and LPA and lifestyle factors with human longevity Nat. Commun. 2017 8 910 10.1038/s41467-017-00934-5 29030599
12. McDaid A.F. Joshi P.K. Porcu E. Komljenovic A. Li H. Sorrentino V. Litovchenko M. Bevers R.P. Rüeger S. Reymond A. Bayesian association scan reveals loci associated with human lifespan and linked biomarkers Nat. Commun. 2017 8 15842 10.1038/ncomms15842 28748955
13. Vedder O. Moiron M. Bichet C. Bauch C. Verhulst S. Becker P.H. Bouwhuis S. Telomere length is heritable and genetically correlated with lifespan in a wild bird Mol. Ecol. 2021 10.1111/mec.15807 33460462
14. Öngel M.E. Yıldız C. Akpınaroğlu C. Yilmaz B. Özilgen M. Why women may live longer than men do? A telomere-length regulated and diet-based entropic assessment Clin. Nutr. 2021 40 1186 1191 10.1016/j.clnu.2020.07.030 32807581
15. Yu Z. Seim I. Yin M. Tian R. Sun D. Ren W. Yang G. Xu S. Comparative analyses of aging-related genes in long-lived mammals provide insights into natural longevity Innovation 2021 2 100108 10.1016/j.xinn.2021.100108
16. Gambini J. Gimeno-Mallench L. Olaso-Gonzalez G. Mastaloudis A. Traber M.G. Monleón D. Borrás C. Viña J. Moderate Red Wine Consumption Increases the Expression of Longevity-Associated Genes in Controlled Human Populations and Extends Lifespan in Drosophila melanogaster Antioxidants 2021 10 301 10.3390/antiox10020301 33669360
17. Morris B.J. Chen R. Donlon T.A. Masaki K.H. Willcox D.C. Allsopp R.C. Willcox B.J. Lifespan extension conferred by mitogen-activated protein kinase kinase kinase 5 (MAP3K5) longevity-associated gene variation is confined to at-risk men with a cardiometabolic disease Aging 2021 13 7953 10.18632/aging.202844 33739303
18. Pawlikowska L. Hu D. Huntsman S. Sung A. Chu C. Chen J. Joyner A.H. Schork N.J. Hsueh W.C. Reiner A.P. Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity Aging Cell 2009 8 460 472 10.1111/j.1474-9726.2009.00493.x 19489743
19. Wilkinson G.S. Adams D.M. Haghani A. Lu A.T. Zoller J. Breeze C.E. Arnold B.D. Ball H.C. Carter G.G. Cooper L.N. DNA methylation predicts age and provides insight into exceptional longevity of bats Nat. Commun. 2021 12 1615 10.1038/s41467-021-21900-2 33712580
20. Schumacher B. Pothof J. Vijg J. Hoeijmakers J.H. The central role of DNA damage in the ageing process Nature 2021 592 695 703 10.1038/s41586-021-03307-7 33911272
21. Orkin J.D. Montague M.J. Tejada-Martinez D. de Manuel M. Del Campo J. Cheves Hernandez S. Di Fiore A. Fontsere C. Hodgson J.A. Janiak M.C. The genomics of ecological flexibility, large brains, and long lives in capuchin monkeys revealed with fecalFACS Proc. Natl. Acad. Sci. USA 2021 118 e2010632118 10.1073/pnas.2010632118 33574059
22. Singh P.P. Demmitt B.A. Nath R.D. Brunet A. The Genetics of Aging: A Vertebrate Perspective Cell 2019 177 200 220 10.1016/j.cell.2019.02.038 30901541
23. Zhang Z.D. Milman S. Lin J.R. Wierbowski S. Yu H. Barzilai N. Gorbunova V. Ladiges W.C. Niedernhofer L.J. Suh Y. Genetics of extreme human longevity to guide drug discovery for healthy ageing Nat. Metab. 2020 2 663 672 10.1038/s42255-020-0247-0 32719537
24. Ang L.S. Cruz R.P. Hendel A. Granville D.J. Apolipoprotein E, an important player in longevity and age-related diseases Exp. Gerontol. 2008 43 615 622 10.1016/j.exger.2008.03.010 18468826
25. Raghavachari N. The Impact of Apolipoprotein E Genetic Variability in Health and Life Span J. Gerontol. Ser. A 2020 75 1855 1857 10.1093/gerona/glaa175
26. Strittmatter W.J. Hill C.B. Molecular biology of apolipoprotein E Curr. Opin. Lipidol. 2002 13 119 123 10.1097/00041433-200204000-00002 11891413
27. Mazzone T. Apolipoprotein E secretion by macrophages: Its potential physiological functions Curr. Opin. Lipidol. 1996 7 303 307 10.1097/00041433-199610000-00008 8937521
28. Feng Z. Lin M. Wu R. The Regulation of Aging and Longevity: A New and Complex Role of p53 Genes Cancer 2011 2 443 452 10.1177/1947601911410223 21779512
29. Zhao Y. Wu L. Yue X. Zhang C. Wang J. Li J. Sun X. Zhu Y. Feng Z. Hu W. A polymorphism in the tumor suppressor p53 affects aging and longevity in mouse models Elife 2018 7 e34701 10.7554/eLife.34701 29557783
30. Brady C.A. Attardi L.D. p53 at a glance J. Cell Sci. 2010 123 2527 2532 10.1242/jcs.064501 20940128
31. Leibiger I.B. Berggren P.-O. Sirt1: A metabolic master switch that modulates lifespan Nat. Med. 2006 12 34 36 10.1038/nm0106-34 16397557
32. Ng F. Wijaya L. Tang B.L. SIRT1 in the brain—connections with aging-associated disorders and lifespan Front. Cell. Neurosci. 2015 9 64 10.3389/fncel.2015.00064 25805970
33. Chen C. Zhou M. Ge Y. Wang X. SIRT1 and aging related signaling pathways Mech. Ageing Dev. 2020 187 111215 10.1016/j.mad.2020.111215 32084459
34. Nogueiras R. Habegger K.M. Chaudhary N. Finan B. Banks A.S. Dietrich M.O. Horvath T.L. Sinclair D.A. Pfluger P.T. Tschöp M.H. Sirtuin 1 and sirtuin 3: Physiological modulators of metabolism Physiol. Rev. 2012 10.1152/physrev.00022.2011 22811431
35. Peng L. Yuan Z. Li Y. Ling H. Izumi V. Fang B. Fukasawa K. Koomen J. Chen J. Seto E. Ubiquitinated sirtuin 1 (SIRT1) function is modulated during DNA damage-induced cell death and survival J. Biol. Chem. 2015 290 8904 8912 10.1074/jbc.M114.612796 25670865
36. Kwon E.S. Narasimhan S.D. Yen K. Tissenbaum H.A. A new DAF-16 isoform regulates longevity Nature 2010 466 498 502 10.1038/nature09184 20613724
37. Sun X. Chen W.D. Wang Y.D. DAF-16/FOXO Transcription Factor in Aging and Longevity Front. Pharmacol. 2017 8 548 10.3389/fphar.2017.00548 28878670
38. Furuyama T. Kitayama K. Shimoda Y. Ogawa M. Sone K. Yoshida-Araki K. Hisatsune H. Nishikawa S.I. Nakayama K. Nakayama K. Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice J. Biol. Chem. 2004 279 34741 34749 10.1074/jbc.M314214200 15184386
39. Joshi P.K. Fischer K. Schraut K.E. Campbell H. Esko T. Wilson J.F. Variants near CHRNA3/5 and APOE have age-and sex-related effects on human lifespan Nat. Commun. 2016 7 11174 10.1038/ncomms11174 27029810
40. Haller G. Kapoor M. Budde J. Xuei X. Edenberg H. Nurnberger J. Kramer J. Brooks A. Tischfield J. Almasy L. Rare missense variants in CHRNB3 and CHRNA3 are associated with risk of alcohol and cocaine dependence Hum. Mol. Genet. 2014 23 810 819 10.1093/hmg/ddt463 24057674
41. Song W. Ren D. Li W. Jiang L. Cho K.W. Huang P. Fan C. Song Y. Liu Y. Rui L. SH2B regulation of growth, metabolism, and longevity in both insects and mammals Cell Metab. 2010 11 427 437 10.1016/j.cmet.2010.04.002 20417156
42. Kuo C.-L. Joaquim M. Kuchel G.A. Ferrucci L. Harries L.W. Pilling L.C. Melzer D. The longevity-associated SH2B3 (LNK) genetic variant: Selected aging phenotypes in 379, 758 subjects J. Gerontol. Ser. A 2020 75 1656 1662 10.1093/gerona/glz191 31428775
43. Maures T.J. Kurzer J.H. Carter-Su C. SH2B1 (SH2-B) and JAK2: A multifunctional adaptor protein and kinase made for each other Trends Endocrinol. Metab. 2007 18 38 45 10.1016/j.tem.2006.11.007 17140804
44. Gery S. Koeffler H.P. Role of the adaptor protein LNK in normal and malignant hematopoiesis Oncogene 2013 32 3111 3118 10.1038/onc.2012.435 23045270
45. Duan C. Yang H. White M.F. Rui L. Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance Mol. Cell. Biol. 2004 24 7435 7443 10.1128/MCB.24.17.7435-7443.2004 15314154
46. Baker D.J. Jin F. Van Deursen J.M. The yin and yang of the Cdkn2a locus in senescence and aging Cell Cycle 2008 7 2795 2802 10.4161/cc.7.18.6687 18769141
47. Sándor S. Tátrai K. Czeibert K. Egyed B. Kubinyi E. CDKN2A gene expression as a potential aging biomarker in dogs Front. Vet. Sci. 2021 8 348 10.3389/fvets.2021.660435
48. Pal A. Potjer T.P. Thomsen S.K. Ng H.J. Barrett A. Scharfmann R. James T.J. Bishop D.T. Karpe F. Godsland I.F. Loss-of-function mutations in the cell-cycle control gene CDKN2A impact on glucose homeostasis in humans Diabetes 2016 65 527 533 10.2337/db15-0602 26542317
49. Kahoul Y. Oger F. Montaigne J. Froguel P. Breton C. Annicotte J.S. Emerging Roles for the INK4a/ARF (CDKN2A) Locus in Adipose Tissue: Implications for Obesity and Type 2 Diabetes Biomolecules 2020 10 1350 10.3390/biom10091350
50. Rabhi N. Hannou S.A. Gromada X. Salas E. Yao X. Oger F. Carney C. Lopez-Mejia I.C. Durand E. Rabearivelo I. Cdkn2a deficiency promotes adipose tissue browning Mol. Metab. 2018 8 65 76 10.1016/j.molmet.2017.11.012 29237539
51. Pegoli G. Milan M. Manti P.G. Bianchi A. Lucini F. Santarelli P. Bearzi C. Rizzi R. Lanzuolo C. Role of Cdkn2a in the Emery–Dreifuss Muscular Dystrophy Cardiac Phenotype Biomolecules 2021 11 538 10.3390/biom11040538 33917623
52. Bacalini M.G. Deelen J. Pirazzini C. De Cecco M. Giuliani C. Lanzarini C. Ravaioli F. Marasco E. Van Heemst D. Suchiman H.E.D. Systemic age-associated DNA hypermethylation of ELOVL2 gene: In vivo and in vitro evidences of a cell replication process J. Gerontol. Ser. A Biomed. Sci. Med. Sci. 2017 72 1015 1023 10.1093/gerona/glw185 27672102
53. Chao D.L. Skowronska-Krawczyk D. ELOVL2: Not just a biomarker of aging Transl. Med. Aging 2020 4 78 80 10.1016/j.tma.2020.06.004 33043173
54. Pauter A.M. Olsson P. Asadi A. Herslöf B. Csikasz R.I. Zadravec D. Jacobsson A. Elovl2 ablation demonstrates that systemic DHA is endogenously produced and is essential for lipid homeostasis in mice [S] J. Lipid Res. 2014 55 718 728 10.1194/jlr.M046151 24489111
55. Bellini L. Campana M. Rouch C. Chacinska M. Bugliani M. Meneyrol K. Hainault I. Lenoir V. Denom J. Véret J. Protective role of the ELOVL2/docosahexaenoic acid axis in glucolipotoxicity-induced apoptosis in rodent beta cells and human islets Diabetologia 2018 61 1780 1793 10.1007/s00125-018-4629-8 29754287
56. Kuningas M. Slagboom P.E. Westendorp R.G. van Heemst D. Impact of genetic variations in the WRN gene on age related pathologies and mortality Mech. Ageing Dev. 2006 127 307 313 10.1016/j.mad.2005.11.005 16405962
57. Ding S.-L. Yu J.-C. Chen S.-T. Hsu G.-C. Shen C.-Y. Genetic variation in the premature aging gene WRN: A case-control study on breast cancer susceptibility Cancer Epidemiol. Prev. Biomark. 2007 16 263 269 10.1158/1055-9965.EPI-06-0678
58. Szekely A.M. Bleichert F. Nümann A. Van Komen S. Manasanch E. Ben Nasr A. Canaan A. Weissman S.M. Werner protein protects nonproliferating cells from oxidative DNA damage Mol. Cell. Biol. 2005 25 10492 10506 10.1128/MCB.25.23.10492-10506.2005 16287861
59. Ozgenc A. Loeb L.A. Current advances in unraveling the function of the Werner syndrome protein Mutat. Res./Fundam. Mol. Mech. Mutagenesis 2005 577 237 251 10.1016/j.mrfmmm.2005.03.020
60. Opresko P.L. Cheng W.H. von Kobbe C. Harrigan J.A. Bohr V.A. Werner syndrome and the function of the Werner protein; what they can teach us about the molecular aging process Carcinogenesis 2003 24 791 802 10.1093/carcin/bgg034 12771022
61. Lescai F. Marchegiani F. Franceschi C. PON1 is a longevity gene: Results of a meta-analysis Ageing Res. Rev. 2009 8 277 284 10.1016/j.arr.2009.04.001 19376276
62. Erdman V.V.N.T. Tuktarova I.A. Timasheva Y.R. Viktorova T.V. The PON1 gene polymorphic marker rs662 is associated with longevity in Bashkirs Биoмика 2020 12 435 441 10.31301/2221-6197.bmcs.2020-34
63. Lacinski M. Skorupski W. Cieslinski A. Sokolowska J. Trzeciak W.H. OF the paraoxonase-1 (PON1) protein in humans Cell. Mol. Biol. 2004 50 885 893 15704252
64. Mackness M.I. Durrington P.N. Mackness B. The role of paraoxonase 1 activity in cardiovascular disease Am. J. Cardiovasc. Drugs 2004 4 211 217 10.2165/00129784-200404040-00002 15285696
65. Van Raamsdonk J.M. Hekimi S. Deletion of the mitochondrial superoxide dismutase sod-2 extends lifespan in Caenorhabditis elegans PLoS Genet. 2009 5 e1000361 10.1371/journal.pgen.1000361 19197346
66. Sun Y. Yolitz J. Alberico T. Sun X. Zou S. Lifespan extension by cranberry supplementation partially requires SOD2 and is life stage independent Exp. Gerontol. 2014 50 57 63 10.1016/j.exger.2013.11.020 24316039
67. Afolayan A.J. Teng R.J. Eis A. Rana U. Broniowska K.A. Corbett J.A. Pritchard K. Konduri G.G. Inducible HSP70 regulates superoxide dismutase-2 and mitochondrial oxidative stress in the endothelial cells from developing lungs Am. J. Physiol. Lung Cell. Mol. Physiol. 2014 306 L351 L360 10.1152/ajplung.00264.2013 24375796
68. Saxena P. Selvaraj K. Khare S.K. Chaudhary N. Superoxide dismutase as multipotent therapeutic antioxidant enzyme: Role in human diseases Biotechnol. Lett. 2021 3 1 22 10.1007/s10529-021-03200-3
69. Conneely K.N. Capell B.C. Erdos M.R. Sebastiani P. Solovieff N. Swift A.J. Baldwin C.T. Budagov T. Barzilai N. Atzmon G. Human longevity and common variations in the LMNA gene: A meta-analysis Aging Cell 2012 11 475 481 10.1111/j.1474-9726.2012.00808.x 22340368
70. Lopez-Mejia I.C. Vautrot V. De Toledo M. Behm-Ansmant I. Bourgeois C.F. Navarro C.L. Osorio F.G. Freije J.M. Stévenin J. De Sandre-Giovannoli A. A conserved splicing mechanism of the LMNA gene controls premature aging Hum. Mol. Genet. 2011 20 4540 4555 10.1093/hmg/ddr385 21875900
71. Cenni V. Capanni C. Mattioli E. Schena E. Squarzoni S. Bacalini M.G. Garagnani P. Salvioli S. Franceschi C. Lattanzi G. Lamin A involvement in ageing processes Ageing Res. Rev. 2020 62 101073 10.1016/j.arr.2020.101073 32446955
72. Carmosino M. Torretta S. Procino G. Gerbino A. Forleo C. Favale S. Svelto M. Role of nuclear Lamin A/C in cardiomyocyte functions Biol. Cell 2014 106 346 358 10.1111/boc.201400033 25055884
73. Soerensen M. Dato S. Tan Q. Thinggaard M. Kleindorp R. Beekman M. Suchiman H.E. Jacobsen R. McGue M. Stevnsner T. Evidence from case-control and longitudinal studies supports associations of genetic variation in APOE, CETP, and IL6 with human longevity Age 2013 35 487 500 10.1007/s11357-011-9373-7 22234866
74. Yang J.K. Gong Y.Y. Xie L. Yang Y. Xu L.Y. Zhang Y.P. Association study of promoter polymorphisms in the CETP gene with longevity in the Han Chinese population Mol. Biol. Rep. 2014 41 325 329 10.1007/s11033-013-2865-z 24242673
75. Banerjee S. De A. Pathophysiology and inhibition of cholesteryl ester transfer protein for prevention of cardiovascular diseases: An update Drug Discov. Today 2021 26 1759 1764 10.1016/j.drudis.2021.03.016 33781947
76. Yamashita S. Hirano K.I. Sakai N. Matsuzawa Y. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein Biochim. Biophys. Acta (BBA)—Mol. Cell Biol. Lipids 2000 1529 257 275 10.1016/S1388-1981(00)00164-5
77. Novelli V. Viviani Anselmi C. Roncarati R. Guffanti G. Malovini A. Piluso G. Puca A.A. Lack of replication of genetic associations with human longevity Biogerontology 2008 9 85 92 10.1007/s10522-007-9116-4 18034366
78. Muenchhoff J. Song F. Poljak A. Crawford J.D. Mather K.A. Kochan N.A. Yang Z. Trollor J.N. Reppermund S. Maston K. Plasma apolipoproteins and physical and cognitive health in very old individuals Neurobiol. Aging 2017 55 49 60 10.1016/j.neurobiolaging.2017.02.017 28419892
79. Buckner T. Shao B. Eckel R.H. Heinecke J.W. Bornfeldt K.E. Snell-Bergeon J. Association of apolipoprotein C3 with insulin resistance and coronary artery calcium in patients with type 1 diabetes J. Clin. Lipidol. 2021 15 235 242 10.1016/j.jacl.2020.10.006 33257283
80. Liu C.C. Kanekiyo T. Xu H. Bu G. Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy Nat. Rev. Neurol. 2013 9 106 118 10.1038/nrneurol.2012.263 23296339
81. Huffman D.M. Deelen J. Ye K. Bergman A. Slagboom E.P. Barzilai N. Atzmon G. Distinguishing between longevity and buffered-deleterious genotypes for exceptional human longevity: The case of the MTP gene J. Gerontol. Ser. A Biol. Sci. Med. Sci. 2012 67 1153 1160 10.1093/gerona/gls103 22496539
82. Hussain M.M. Rava P. Walsh M. Rana M. Iqbal J. Multiple functions of microsomal triglyceride transfer protein Nutr. Metab. 2012 9 14 10.1186/1743-7075-9-14 22353470
83. Iqbal J. Jahangir Z. Al-Qarni A.A. Microsomal triglyceride transfer protein: From lipid metabolism to metabolic diseases Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease Springer Singapore 2020 37 52
84. Xie S. Ni J. Guo H. Luu V. Wang Y. Zhao J.J. Roberts T.M. The role of the PIK3CA gene in the development and aging of the brain Sci. Rep. 2021 11 291 10.1038/s41598-020-79416-6 33431926
85. Ditlevsen D.K. Køhler L.B. Pedersen M.V. Risell M. Kolkova K. Meyer M. Berezin V. Bock E. The role of phosphatidylinositol 3-kinase in neural cell adhesion molecule-mediated neuronal differentiation and survival J. Neurochem. 2003 84 546 556 10.1046/j.1471-4159.2003.01538.x 12558974
86. Xing M. Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer Thyroid 2010 20 697 706 10.1089/thy.2010.1646 20578891
87. Ihle N.T. Powis G. Take your PIK: Phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy Mol. Cancer Ther. 2009 8 1 9 10.1158/1535-7163.MCT-08-0801 19139107
88. Pietsch K. Saul N. Menzel R. Stürzenbaum S.R. Steinberg C.E. Quercetin mediated lifespan extension in Caenorhabditis elegans is modulated by age-1, daf-2, sek-1 and unc-43 Biogerontology 2009 10 565 578 10.1007/s10522-008-9199-6 19043800
89. Ayyadevara S. Dandapat A. Singh S.P. Benes H. Zimniak L. Shmookler Reis R.J. Zimniak P. Lifespan extension in hypomorphic daf-2 mutants of Caenorhabditis elegans is partially mediated by glutathione transferase CeGSTP2-2 Aging Cell 2005 4 299 307 10.1111/j.1474-9726.2005.00172.x 16300482
90. Laron Z. Insulin-like growth factor 1 (IGF-1): A growth hormone Mol. Pathol. 2001 54 311 10.1136/mp.54.5.311 11577173
91. Larsson O. Girnita A. Girnita L. Role of insulin-like growth factor 1 receptor signalling in cancer Br. J. Cancer 2005 92 2097 2101 10.1038/sj.bjc.6602627 15956962
92. Amer M. Elhefnawi M. El-Ahwany E. Awad A.F. Gawad N.A. Zada S. Tawab F.M. Hsa-miR-195 targets PCMT1 in hepatocellular carcinoma that increases tumor life span Tumour Biol. J. Int. Soc. Oncodev. Biol. Med. 2014 35 11301 11309 10.1007/s13277-014-2445-4 25119594
93. Furuchi T. Sakurako K. Katane M. Sekine M. Homma H. The role of protein L-isoaspartyl/D-aspartyl O-methyltransferase (PIMT) in intracellular signal transduction Chem. Biodivers. 2010 7 1337 1348 10.1002/cbdv.200900273 20564550
94. Shimizu T. Ikegami T. Ogawara M. Suzuki Y.I. Takahashi M. Morio H. Shirasawa T. Transgenic expression of the protein-L-isoaspartyl methyltransferase (PIMT) gene in the brain rescues mice from the fatal epilepsy of PIMT deficiency J. Neurosci. Res. 2002 69 341 352 10.1002/jnr.10301 12125075
95. Van Heemst D. Insulin, IGF-1 and longevity Aging Dis. 2010 1 147 157 22396862
96. López-Otín C. Galluzzi L. Freije J.M.P. Madeo F. Kroemer G. Metabolic Control of Longevity Cell 2016 166 802 821 10.1016/j.cell.2016.07.031 27518560
97. Waters M.J. Kaye P.L. The role of growth hormone in fetal development Growth Horm. IGF Res. 2002 1 137 146 10.1016/S1096-6374(02)00018-7
98. Vijayakumar A. Yakar S. Le Roith D. The intricate role of growth hormone in metabolism Front. Endocrinol. 2011 2 32 10.3389/fendo.2011.00032
99. Bartke A. Growth hormone and aging: Updated review World J. Men’s Health 2019 37 19 30 10.5534/wjmh.180018 29756419
100. Mahesh S. Kaskel F. Growth hormone axis in chronic kidney disease Pediatr. Nephrol. 2008 23 41 48 10.1007/s00467-007-0527-x 17676425
101. Yokoyama J.S. Sturm V.E. Bonham L.W. Klein E. Arfanakis K. Yu L. Coppola G. Kramer J.H. Bennett D.A. Miller B.L. Variation in longevity gene KLOTHO is associated with greater cortical volumes Ann. Clin. Transl. Neurol. 2015 2 215 230 10.1002/acn3.161 25815349
102. Di Bona D. Accardi G. Virruso C. Candore G. Caruso C. Association of Klotho polymorphisms with healthy aging: A systematic review and meta-analysis Rejuvenation Res. 2014 17 212 216 10.1089/rej.2013.1523 24164579
103. Dias G.P. Murphy T. Stangl D. Ahmet S. Morisse B. Nix A. Aimone L.J. Aimone J.B. Kuro O.M. Gage F.H. Intermittent fasting enhances long-term memory consolidation, adult hippocampal neurogenesis, and expression of longevity gene Klotho Mol. Psychiatry 2021 1 15 10.1038/s41380-021-01102-4 34031536
104. Zimmermann M. Köhler L. Kovarova M. Lerche S. Schulte C. Wurster I. Machetanz G. Deuschle C. Hauser A.K. Gasser T. The longevity gene Klotho and its cerebrospinal fluid protein profiles as a modifier for Parkinson’s disease Eur. J. Neurol. 2021 28 1557 1565 10.1111/ene.14733 33449400
105. Bian A. Xing C. Hu M.C. Alpha Klotho and phosphate homeostasis J. Endocrinol. Investig. 2014 37 1121 1126 10.1007/s40618-014-0158-6 25194425
106. Kim J.H. Hwang K.H. Park K.S. Kong I.D. Cha S.K. Biological role of anti-aging protein Klotho J. Lifestyle Med. 2015 5 1 10.15280/jlm.2015.5.1.1 26528423
107. Mencke R. Hillebrands J.L. NIGRAM consortium. The role of the anti-ageing protein Klotho in vascular physiology and pathophysiology Ageing Res. Rev. 2017 35 124 146 10.1016/j.arr.2016.09.001 27693241
108. Saar-Kovrov V. Donners M.M. Van Der Vorst E.P. Shedding of Klotho: Functional Implications in Chronic Kidney Disease and Associated Vascular Disease Front. Cardiovasc. Med. 2021 7 407 10.3389/fcvm.2020.617842
109. Mair W. Morantte I. Rodrigues A.P. Manning G. Montminy M. Shaw R.J. Dillin A. Lifespan extension induced by AMPK and calcineurin is mediated by CRTC-1 and CREB Nature 2011 470 404 408 10.1038/nature09706 21331044
110. Chen Y.C. Chen H.J. Tseng W.C. Hsu J.M. Huang T.T. Chen C.H. Pan C.L. A C. elegans Thermosensory Circuit Regulates Longevity through crh-1/CREB-Dependent flp-6 Neuropeptide Signaling Dev. Cell 2016 39 209 223 10.1016/j.devcel.2016.08.021 27720609
111. Sakamoto K. Karelina K. Obrietan K. CREB: A multifaceted regulator of neuronal plasticity and protection J. Neurochem. 2011 116 1 9 10.1111/j.1471-4159.2010.07080.x 21044077
112. Lee A.H. The role of CREB-H transcription factor in triglyceride metabolism Curr. Opin. Lipidol. 2012 23 141 10.1097/MOL.0b013e3283508fed 22262056
113. Amidfar M. de Oliveira J. Kucharska E. Budni J. Kim Y.K. The role of CREB and BDNF in neurobiology and treatment of Alzheimer’s disease Life Sci. 2020 257 118020 10.1016/j.lfs.2020.118020 32603820
114. Ge Y. Chen H. Wang J. Liu G. Cui S.W. Kang J. Jiang Y. Wang H. Naringenin prolongs lifespan and delays aging mediated by IIS and MAPK in Caenorhabditis elegans Food Funct. 2021 12 12127 12141 10.1039/D1FO02472H 34787618
115. Matilainen O. Ribeiro A.R.S. Verbeeren J. Cetinbas M. Sood H. Sadreyev R.I. Garcia S. Loss of muscleblind splicing factor shortens Caenorhabditis elegans lifespan by reducing the activity of p38 MAPK/PMK-1 and transcription factors ATF-7 and Nrf/SKN-1 Genetics 2021 219 iyab114 10.1093/genetics/iyab114 34849877
116. Salojin K.V. Owusu I.B. Millerchip K.A. Potter M. Platt K.A. Oravecz T. Essential role of MAPK phosphatase-1 in the negative control of innate immune responses J. Immunol. 2006 176 1899 1907 10.4049/jimmunol.176.3.1899 16424221
117. De Zelicourt A. Colcombet J. Hirt H. The role of MAPK modules and ABA during abiotic stress signaling Trends Plant Sci. 2016 21 677 685 10.1016/j.tplants.2016.04.004 27143288
118. Zhu X. Lee H.G. Raina A.K. Perry G. Smith M.A. The role of mitogen-activated protein kinase pathways in Alzheimer’s disease Neurosignals 2002 11 270 281 10.1159/000067426 12566928
119. Bernardo B.C. Weeks K.L. Pretorius L. McMullen J.R. Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies Pharmacol. Ther. 2010 128 191 227 10.1016/j.pharmthera.2010.04.005 20438756
120. Akhoon B.A. Rathor L. Pandey R. Withanolide A extends the lifespan in human EGFR-driven cancerous Caenorhabditis elegans Exp. Gerontol. 2018 104 113 117 10.1016/j.exger.2018.02.004 29427754
121. Kunugi H. Mohammed Ali A. Royal Jelly and Its Components Promote Healthy Aging and Longevity: From Animal Models to Humans Int. J. Mol. Sci. 2019 20 4662 10.3390/ijms20194662
122. Romano R. Bucci C. Role of EGFR in the Nervous System Cells 2020 9 1887 10.3390/cells9081887
123. Breitbart H. Etkovitz N. Role and regulation of EGFR in actin remodeling in sperm capacitation and the acrosome reaction Asian J. Androl. 2011 13 106 10.1038/aja.2010.78 21200378
124. Sigismund S. Avanzato D. Lanzetti L. Emerging functions of the EGFR in cancer Mol. Oncol. 2018 12 3 20 10.1002/1878-0261.12155 29124875
125. Salminen A. Ojala J. Huuskonen J. Kauppinen A. Suuronen T. Kaarniranta K. Interaction of aging-associated signaling cascades: Inhibition of NF-kappaB signaling by longevity factors FoxOs and SIRT1 Cell. Mol. Life Sci. CMLS 2008 65 1049 1058 10.1007/s00018-008-7461-3 18193389
126. Ryu S. Han J. Norden-Krichmar T.M. Zhang Q. Lee S. Zhang Z. Atzmon G. Niedernhofer L.J. Robbins P.D. Barzilai N. Genetic signature of human longevity in PKC and NF-κB signaling Aging Cell 2021 20 e13362 10.1111/acel.13362 34197020
127. Tripathi P. Aggarwal A. NF-kB transcription factor: A key player in the generation of immune response Curr. Sci. 2006 25 519 531
128. Caviedes A. Lafourcade C. Soto C. Wyneken U. BDNF/NF-κB signaling in the neurobiology of depression Curr. Pharm. Des. 2017 23 3154 3163 10.2174/1381612823666170111141915 28078988
129. Coto E. Reguero J.R. Avanzas P. Pascual I. Martín M. Hevia S. Morís C. Díaz-Molina B. Lambert J.L. Alonso B. Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and risk for early-onset coronary artery disease Immunol. Lett. 2019 208 39 43 10.1016/j.imlet.2019.02.007 30902734
130. Zinatizadeh M.R. Schock B. Chalbatani G.M. Zarandi P.K. Jalali S.A. Miri S.R. The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases Genes Dis. 2021 8 287 297 10.1016/j.gendis.2020.06.005 33997176
131. Wong C.O. Karagas N.E. Jung J. Wang Q. Rousseau M.A. Chao Y. Insolera R. Soppina P. Collins C.A. Zhou Y. Regulation of longevity by depolarization-induced activation of PLC-β-IP(3)R signaling in neurons Proc. Natl. Acad. Sci. USA 2021 118 3118 10.1073/pnas.2004253118
132. Bill C.A. Vines C.M. Phospholipase, C Calcium Signal 2020 215 242
133. Rusciano I. Marvi M.V. Obeng E.O. Mongiorgi S. Ramazzotti G. Follo M.Y. Zoli M. Morandi L. Asioli S. Fabbri V.P. Location-dependent role of phospholipase C signaling in the brain: Physiology and pathology Adv. Biol. Regul. 2021 79 100771 10.1016/j.jbior.2020.100771 33303387
134. Lattanzio R. Piantelli M. Falasca M. Role of phospholipase C in cell invasion and metastasis Adv. Biol. Regul. 2013 53 309 318 10.1016/j.jbior.2013.07.006 23925006
135. Salmon A.B. Kim G. Liu C. Wren J.D. Georgescu C. Richardson A. Levine R.L. Effects of transgenic methionine sulfoxide reductase A (MsrA) expression on lifespan and age-dependent changes in metabolic function in mice Redox Biol. 2016 10 251 256 10.1016/j.redox.2016.10.012 27821326
136. Ruan H. Tang X.D. Chen M.L. Joiner M.A. Sun G. Brot N. Weissbach H. Heinemann S.H. Iverson L. Wu C.F. High-quality life extension by the enzyme peptide methionine sulfoxide reductase Proc. Natl. Acad. Sci. USA 2002 99 2748 2753 10.1073/pnas.032671199 11867705
137. Zhao H. Sun J. Deschamps A.M. Kim G. Liu C. Murphy E. Levine R.L. Myristoylated methionine sulfoxide reductase A protects the heart from ischemia-reperfusion injury Am. J. Physiol. Heart Circ. Physiol. 2011 301 H1513 H1518 10.1152/ajpheart.00441.2011 21841012
138. Jiang B. Moskovitz J. The functions of the mammalian methionine sulfoxide reductase system and related diseases Antioxidants 2018 7 122 10.3390/antiox7090122
139. Ewald C.Y. Hourihan J.M. Bland M.S. Obieglo C. Katic I. Moronetti Mazzeo L.E. Alcedo J. Blackwell T.K. Hynes N.E. NADPH oxidase-mediated redox signaling promotes oxidative stress resistance and longevity through memo-1 in C. elegans eLife 2017 6 19493 10.7554/eLife.19493
140. Schotanus M.D. Van Otterloo E. Finding MEMO—Emerging Evidence for MEMO1′s Function in Development and Disease Genes 2020 11 1316 10.3390/genes11111316
141. Hooten N.N. Fitzpatrick M. Kompaniez K. Jacob K.D. Moore B.R. Nagle J. Barnes J. Lohani A. Evans M. Coordination of DNA repair by NEIL1 and PARP-1: A possible link to aging Aging 2012 4 674 685 10.18632/aging.100492 23104860
142. Han D. Schomacher L. Schüle K.M. Mallick M. Musheev M.U. Karaulanov E. Krebs L. Von Seggern A. Niehrs C. Author response: NEIL1 and NEIL2 DNA glycosylases protect neural crest development against mitochondrial oxidative stress eLife 2019 8 e49044 10.7554/eLife.49044 31566562
143. Kwiatkowski D. Czarny P. Toma M. Korycinska A. Sowinska K. Galecki P. Bachurska A. Bielecka-Kowalska A. Szemraj J. Maes M. Association between Single-Nucleotide Polymorphisms of the hOGG1,NEIL1,APEX1, FEN1,LIG1, and LIG3 Genes and Alzheimer’s Disease Risk Neuropsychobiology 2016 73 98 107 10.1159/000444643 27010693
144. Argmann C. Dobrin R. Heikkinen S. Auburtin A. Pouilly L. Cock T.-A. Koutnikova H. Zhu J. Schadt E.E. Auwerx J. Pparγ2 Is a Key Driver of Longevity in the Mouse PLoS Genet. 2009 5 e1000752 10.1371/journal.pgen.1000752 19997628
145. Xu L. Ma X. Verma N. Perie L. Pendse J. Shamloo S. Josephson A.M. Wang D. Qiu J. Guo M. PPARγ agonists delay age-associated metabolic disease and extend longevity Aging Cell 2020 19 e13267 10.1111/acel.13267 33219735
146. Ge K. Guermah M. Yuan C.-X. Ito M. Wallberg A.E. Spiegelman B.M. Roeder R.G. Transcription coactivator TRAP220 is required for PPARγ2-stimulated adipogenesis Nature 2002 417 563 567 10.1038/417563a 12037571
147. Li Y. Zhu J. Ding J. Association of the PPARγ2 Pro12Ala polymorphism with increased risk of cardiovascular diseases Genet. Mol. Res. 2015 14 18662 18674 10.4238/2015.December.28.15 26782516
148. Cattie D.J. Richardson C.E. Reddy K.C. Ness-Cohn E.M. Droste R. Thompson M.K. Gilbert W.V. Kim D.H. Mutations in Nonessential eIF3k and eIF3l Genes Confer Lifespan Extension and Enhanced Resistance to ER Stress in Caenorhabditis elegans PLoS Genet. 2016 12 e1006326 10.1371/journal.pgen.1006326 27690135
149. Lin Y.M. Chen Y.R. Lin J.R. Wang W.J. Inoko A. Inagaki M. Wu Y.C. Chen R.H. eIF3k regulates apoptosis in epithelial cells by releasing caspase 3 from keratin-containing inclusions J. Cell Sci. 2008 121 2382 2393 10.1242/jcs.021394 18577580
150. Wang D. Jia Y. Zheng W. Li C. Cui W. Overexpression of eIF3D in lung adenocarcinoma is a new independent prognostic marker of poor survival Dis. Markers 2019 2019 6019637 10.1155/2019/6019637 31885740
151. Qian M. Liu Z. Peng L. Tang X. Meng F. Ao Y. Zhou M. Wang M. Cao X. Qin B. Boosting ATM activity alleviates aging and extends lifespan in a mouse model of progeria eLife 2018 7 e34836 10.7554/eLife.34836 29717979
152. Shiloh Y. Ziv Y. The ATM protein kinase: Regulating the cellular response to genotoxic stress, and more Nat. Rev. Mol. Cell Biol. 2013 14 197 210 10.1038/nrm3546 23847781
153. Ding X. He Y. Hao Q. Chen S. Yang M. Leng S.X. Yue J. Dong B. The association of single nucleotide polymorphism rs189037C> T in ATM gene with coronary artery disease in Chinese Han populations: A case control study Medicine 2018 97 e9747 10.1097/MD.0000000000009747 29369221
154. Pause F.G. Wacker P. Sappino P. ATM gene and lymphoid malignancies Leukemia 2003 18 238 242 10.1038/sj.leu.2403221
155. Fernández Á.F. Sebti S. Wei Y. Zou Z. Shi M. McMillan K.L. He C. Ting T. Liu Y. Chiang W.-C. Disruption of the beclin 1–BCL2 autophagy regulatory complex promotes longevity in mice Nature 2018 558 136 140 10.1038/s41586-018-0162-7 29849149
156. Hardwick J.M. Soane L. Multiple Functions of BCL-2 Family Proteins Cold Spring Harb. Perspect. Biol. 2013 5 a008722 10.1101/cshperspect.a008722 23378584
157. Sassone J. Maraschi A.M. Sassone F. Silani V. Ciammola A. Defining the role of the Bcl-2 family proteins in Huntington’s disease Cell Death Dis. 2013 4 e772 10.1038/cddis.2013.300 23949221
158. Wang L. Yang L. Debidda M. Witte D. Zheng Y. Cdc42 GTPase-activating protein deficiency promotes genomic instability and premature aging-like phenotypes Proc. Natl. Acad. Sci. USA 2007 104 1248 1253 10.1073/pnas.0609149104 17227869
159. Florian M.C. Leins H. Gobs M. Han Y. Marka G. Soller K. Vollmer A. Sakk V. Nattamai K.J. Rayes A. Inhibition of Cdc42 activity extends lifespan and decreases circulating inflammatory cytokines in aged female C57BL/6 mice Aging Cell 2020 19 e13208 10.1111/acel.13208 32755011
160. Florian M.C. Dörr K. Niebel A. Daria D. Schrezenmeier H. Rojewski M. Filippi M.-D. Hasenberg A. Gunzer M. Scharffetter-Kochanek K. Cdc42 Activity Regulates Hematopoietic Stem Cell Aging and Rejuvenation Cell Stem Cell 2012 10 520 530 10.1016/j.stem.2012.04.007 22560076
161. Druso J.E. Endo M. Lin M.-C.J. Peng X. Antonyak M.A. Meller S. Cerione R.A. An Essential Role for Cdc42 in the Functioning of the Adult Mammary Gland J. Biol. Chem. 2016 291 8886 8895 10.1074/jbc.M115.694349 26912661
162. Geiger H. Zheng Y. Cdc42 and aging of hematopoietic stem cells Curr. Opin. Hematol. 2013 20 295 300 10.1097/MOH.0b013e3283615aba 23615056
163. Streeper R.S. Grueter C.A. Salomonis N. Cases S. Levin M.C. Koliwad S.K. Zhou P. Hirschey M. Verdin E. Farese R.V. Deficiency of the lipid synthesis enzyme, DGAT1, extends longevity in mice Aging 2012 4 13 27 10.18632/aging.100424 22291164
164. Johnson A.A. Stolzing A. The role of lipid metabolism in aging, lifespan regulation, and age-related disease Aging Cell 2019 18 e13048 10.1111/acel.13048 31560163
165. Yamazaki T. Sasaki E. Kakinuma C. Yano T. Miura S. Ezaki O. Increased Very Low Density Lipoprotein Secretion and Gonadal Fat Mass in Mice Overexpressing Liver DGAT1 J. Biol. Chem. 2005 280 21506 21514 10.1074/jbc.M412989200 15797871
166. Haas J. Winter H.S. Lim E. Kirby A. Blumenstiel B. DeFelice M. Gabriel S. Jalas C. Branski D. Grueter C. DGAT1 mutation is linked to a congenital diarrheal disorder J. Clin. Investig. 2012 122 4680 4684 10.1172/JCI64873 23114594
167. Zimmerman S.M. Kim S.K. The GATA transcription factor/ MTA-1 homolog egr-1 promotes longevity and stress resistance in C aenorhabditis elegans Aging Cell 2013 13 329 339 10.1111/acel.12179 24304470
168. Tazearslan C. Huang J. Barzilai N. Suh Y. Impaired IGF1R signaling in cells expressing longevity-associated human IGF1R alleles Aging Cell 2011 10 551 554 10.1111/j.1474-9726.2011.00697.x 21388493
169. Sun L.Y. Spong A. Swindell W.R. Fang Y. Hill C. Huber J.A. Boehm J.D. Westbrook R. Salvatori R. Bartke A. Growth hormone-releasing hormone disruption extends lifespan and regulates response to caloric restriction in mice eLife 2013 2 e01098 10.7554/eLife.01098 24175087
170. Li T.-T. Liu M.-R. Pei D.-S. Friend or foe, the role of EGR-1 in cancer Med. Oncol. 2019 37 7 10.1007/s12032-019-1333-6 31748910
171. Kuro-O M. Aging and FGF23-klotho system Vitam. Horm. 2021 115 317 332 10.1016/bs.vh.2020.12.013 33706952
172. Shimada T. Kakitani M. Yamazaki Y. Hasegawa H. Takeuchi Y. Fujita T. Fukumoto S. Tomizuka K. Yamashita T. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism J. Clin. Investig. 2004 113 561 568 10.1172/JCI200419081 14966565
173. Quarles L.D. Role of FGF23 in vitamin D and phosphate metabolism: Implications in chronic kidney disease Exp. Cell Res. 2012 318 1040 1048 10.1016/j.yexcr.2012.02.027 22421513
174. Salminen A. Kaarniranta K. Kauppinen A. Regulation of longevity by FGF21: Interaction between energy metabolism and stress responses Ageing Res. Rev. 2017 37 79 93 10.1016/j.arr.2017.05.004 28552719
175. Yan J. Nie Y. Cao J. Luo M. Yan M. Chen Z. He B. The Roles and Pharmacological Effects of FGF21 in Preventing Aging-Associated Metabolic Diseases Front. Cardiovasc. Med. 2021 8 221 10.3389/fcvm.2021.655575 33869312
176. Fujii N. Uta S. Kobayashi M. Sato T. Okita N. Higami Y. Impact of aging and caloric restriction on fibroblast growth factor 21 signaling in rat white adipose tissue Exp. Gerontol. 2019 118 55 64 10.1016/j.exger.2019.01.001 30620889
177. Fisher F.M. Maratos-Flier E. Understanding the Physiology of FGF21 Annu. Rev. Physiol. 2016 78 223 241 10.1146/annurev-physiol-021115-105339 26654352
178. Cheng P. Zhang F. Yu L. Lin X. He L. Li X. Lu X. Yan X. Tan Y. Zhang C. Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases J. Diabetes Res. 2016 2016 1540267 10.1155/2016/1540267 27247947
179. Torres G.G. Nygaard M. Caliebe A. Blanché H. Chantalat S. Galan P. Lieb W. Christiansen L. Deleuze J.-F. Christensen K. Exome-Wide Association Study Identifies FN3KRP and PGP as New Candidate Longevity Genes J. Gerontol. Ser. A Boil. Sci. Med Sci. 2021 76 786 795 10.1093/gerona/glab023
180. Szwergold B. A Hypothesis: Fructosamine-3-Kinase-Related-Protein (FN3KRP) Catalyzes Deglycation of Maillard Intermediates Directly Downstream from Fructosamines Rejuvenation Res. 2021 24 310 318 10.1089/rej.2021.0009 34314247
181. Possik E. Madiraju S.M. Prentki M. Glycerol-3-phosphate phosphatase/PGP: Role in intermediary metabolism and target for cardiometabolic diseases Biochimie 2017 143 18 28 10.1016/j.biochi.2017.08.001 28826615
182. Selman C. Partridge L. Withers D. Replication of Extended Lifespan Phenotype in Mice with Deletion of Insulin Receptor Substrate 1 PLoS ONE 2011 6 e16144 10.1371/journal.pone.0016144 21283571
183. Selman C. Lingard S. Choudhury A.I. Batterham R.L. Claret M. Clements M. Ramadani F. Okkenhaug K. Schuster E. Blanc E. Evidence for lifespan extension and delayed age–related biomarkers in insulin receptor substrate 1 null mice FASEB J. 2008 22 807 818 10.1096/fj.07-9261com 17928362
184. Liberman Z. Eldar-Finkelman H. Serine 332 Phosphorylation of Insulin Receptor Substrate-1 by Glycogen Synthase Kinase-3 Attenuates Insulin Signaling J. Biol. Chem. 2005 280 4422 4428 10.1074/jbc.M410610200 15574412
185. Baroni M.G. D’Andrea M.P. Montali A. Pannitteri G. Barillà F. Campagna F. Mazzei E. Lovari S. Seccareccia F. Campa P.P. A Common Mutation of the Insulin Receptor Substrate-1 Gene Is A Risk Factor for Coronary Artery Disease Arter. Thromb. Vasc. Biol. 1999 19 2975 2980 10.1161/01.ATV.19.12.2975 10591678
186. Yarchoan M. Toledo J. Lee E.B. Arvanitakis Z. Kazi H. Han L.-Y. Louneva N. Lee V.M.-Y. Kim S.F. Trojanowski J.Q. Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer’s disease and tauopathies Acta Neuropathol. 2014 128 679 689 10.1007/s00401-014-1328-5 25107476
187. Gu M. Shen L. Bai L. Gao J. Marshall C. Wu T. Ding J. Miao D. Xiao M. Heterozygous knockout of the Bmi-1 gene causes an early onset of phenotypes associated with brain aging Age 2013 36 129 139 10.1007/s11357-013-9552-9 23771506
188. Lee J.Y. Yu K.-R. Kim H.-S. Kang I. Kim J.-J. Lee B.-C. Choi S.W. Shin J.-H. Seo Y. Kang K.-S. BMI1 inhibits senescence and enhances the immunomodulatory properties of human mesenchymal stem cells via the direct suppression of MKP-1/DUSP1 Aging 2016 8 1670 1689 10.18632/aging.101000 27454161
189. Abdouh M. Chatoo W. El Hajjar J. David J. Ferreira J. Bernier G. Bmi1 Is Down-Regulated in the Aging Brain and Displays Antioxidant and Protective Activities in Neurons PLoS ONE 2012 7 e31870 10.1371/journal.pone.0031870 22384090
190. Sahasrabuddhe A.A. BMI1: A Biomarker of Hematologic Malignancies Biomarkers Cancer 2016 8 BIC.S33376-75 10.4137/BIC.S33376
191. Bhattacharya R. Mustafi S.B. Street M. Dey A. Dwivedi S.K. Bmi-1: At the crossroads of physiological and pathological biology Genes Dis. 2015 2 225 239 10.1016/j.gendis.2015.04.001 26448339
192. Edrey Y.H. Casper D. Huchon D. Mele J. Gelfond J.A. Kristan D.M. Nevo E. Buffenstein R. Sustained high levels of neuregulin-1 in the longest-lived rodents; a key determinant of rodent longevity Aging Cell 2011 11 213 222 10.1111/j.1474-9726.2011.00772.x 22103690
193. Spivak D. Zhekalov A. Nyrov V. Shapovalov P. Spivak I. Creativity and Its Genetic Foundations International Conference on Professional Culture of the Specialist of the Future Springer Cham, Switzerland 2021 72 86
194. Dang R. Guo Y. Zhu Y. Yang R. Cai H. Jiang P. Chronic administration of calcitriol enhanced neuregulin-1/ErbB signaling in rat myocardium Pharm. Int. J. Pharm. Sci. 2016 71 192 195
195. Cheret C. Willem M. Fricker F.R. Wende H. Wulf-Goldenberg A. Tahirovic S. Nave K.-A. Saftig P. Haass C. Garratt A.N. Bace1 and Neuregulin-1 cooperate to control formation and maintenance of muscle spindles EMBO J. 2013 32 2015 2028 10.1038/emboj.2013.146 23792428
196. Harrison P.J. Law A.J. Neuregulin 1 and SchizophreniA Genetics, Gene Expression, and Neurobiology Biol. Psychiatry 2006 60 132 140 10.1016/j.biopsych.2005.11.002 16442083
197. Erdman V. Nasibullin T.R. Tuktarova I.A. Somova R.S. Mustafina O.E. Association Analysis of Polymorphic Gene Variants in the JAK/STAT Signaling Pathway with Aging and Longevity Russ. J. Genet. 2019 55 728 737 10.1134/S1022795419050077
198. Hofmann P. Sommer J. Theodorou K. Kirchhof L. Fischer A. Li Y. Perisic L. Hedin U. Maegdefessel L. Dimmeler S. Long non-coding RNA H19 regulates endothelial cell aging via inhibition of STAT3 signalling Cardiovasc. Res. 2018 115 230 242 10.1093/cvr/cvy206
199. Awasthi N. Liongue C. Ward A.C. STAT proteins: A kaleidoscope of canonical and non-canonical functions in immunity and cancer J. Hematol. Oncol. 2021 14 198 10.1186/s13045-021-01214-y 34809691
200. Lorenzini T. Dotta L. Giacomelli M. Vairo D. Badolato R. STAT mutations as program switchers: Turning primary immuno-deficiencies into autoimmune diseases J. Leukoc. Biol. 2017 101 29 38 10.1189/jlb.5RI0516-237RR 27803128
201. Gu Y. Mohammad I.S. Liu Z. Overview of the STAT-3 signaling pathway in cancer and the development of specific inhibitors Oncol. Lett. 2020 19 2585 2594 10.3892/ol.2020.11394 32218808
202. Yamasaki L. Bronson R. Williams B.O. Dyson N.J. Harlow E. Jacks T. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1 (+/−) mice Nat. Genet. 1998 18 360 364 10.1038/ng0498-360 9537419
203. Xie Q. Peng S. Tao L. Ruan H. Yang Y. Li T.-M. Adams U. Meng S. Bi X. Dong M.-Q. E2F Transcription Factor 1 Regulates Cellular and Organismal Senescence by Inhibiting Forkhead Box O Transcription Factors J. Biol. Chem. 2014 289 34205 34213 10.1074/jbc.M114.587170 25344604
204. Warg L.A. Oakes J.L. Burton R. Neidermyer A.J. Rutledge H.R. Groshong S. Schwartz D.A. Yang I.V. The role of the E2F1 tran-scription factor in the innate immune response to systemic LPS Am. J. Physiol. Lung Cell. Mol. Physiol. 2012 303 L391 L400 10.1152/ajplung.00369.2011 22707615
205. Denechaud P.-D. Fajas L. Giralt A. E2F1, a Novel Regulator of Metabolism Front. Endocrinol. 2017 8 311 10.3389/fendo.2017.00311 29176962
206. Mandigo A.C. Yuan W. Xu K. Gallagher P. Pang A. Guan Y.F. Shafi A.A. Thangavel C. Sheehan B. Bogdan D. RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced Disease Cancer Discov. 2021 11 2334 2353 10.1158/2159-8290.CD-20-1114 33879449
207. Grunewald M. Kumar S. Sharife H. Volinsky E. Gileles-Hillel A. Licht T. Permyakova A. Hinden L. Azar S. Friedmann Y. Counteracting age-related VEGF signaling insufficiency promotes healthy aging and extends life span Science 2021 373 eabc8479 10.1126/science.abc8479 34326210
208. Del Bo R. Ghezzi S. Scarlato M. Albani D. Galimberti D. Lucca U. Tettamanti M. Scarpini E. Forloni G. Bresolin N. Role of VEGF gene variability in longevity: A lesson from the Italian population Neurobiol. Aging 2008 29 1917 1922 10.1016/j.neurobiolaging.2007.05.003 17574707
209. Matsumoto K. Ema M. Roles of VEGF-A signalling in development, regeneration, and tumours J. Biochem. 2014 156 1 10 10.1093/jb/mvu031 24839295
210. Tyshkovskiy A. Bozaykut P. Borodinova A.A. Gerashchenko M.V. Ables G.P. Garratt M. Khaitovich P. Clish C. Miller R.A. Gladyshev V.N. Identification and Application of Gene Expression Signatures Associated with Lifespan Extension Cell Metab. 2019 30 573 593.e8 10.1016/j.cmet.2019.06.018 31353263
211. Steinbaugh M. Sun L.Y. Bartke A. Miller R.A. Activation of genes involved in xenobiotic metabolism is a shared signature of mouse models with extended lifespan Am. J. Physiol. Metab. 2012 303 E488 E495 10.1152/ajpendo.00110.2012
212. Crocco P. Montesanto A. Dato S. Geracitano S. Iannone F. Passarino G. Rose G. Inter-individual variability in xenobi-otic-metabolizing enzymes: Implications for human aging and longevity Genes 2019 10 403 10.3390/genes10050403
213. Shore D.E. Ruvkun G. A cytoprotective perspective on longevity regulation Trends Cell Biol. 2013 23 409 420 10.1016/j.tcb.2013.04.007 23726168
214. Hofmann J.W. Zhao X. De Cecco M. Peterson A.L. Pagliaroli L. Manivannan J. Hubbard G.B. Ikeno Y. Zhang Y. Feng B. Reduced Expression of MYC Increases Longevity and Enhances Healthspan Cell 2015 160 477 488 10.1016/j.cell.2014.12.016 25619689
215. Carroll P.A. Eisenman R.N. Growing old with Myc Cell 2015 160 365 366 10.1016/j.cell.2015.01.018 25635453
216. Neumann B. Segel M. Ghosh T. Zhao C. Tourlomousis P. Young A. Förster S. Sharma A. Chen C.Z.-Y. Cubillos J.F. Myc determines the functional age state of oligodendrocyte progenitor cells Nat. Aging 2021 1 826 837 10.1038/s43587-021-00109-4
217. Marinkovic D. Marinkovic T. The new role for an old guy: MYC as an immunoplayer J. Cell. Physiol. 2020 236 3234 3243 10.1002/jcp.30123 33094851
218. Spinetti G. Sangalli E. Specchia C. Villa F. Spinelli C.C. Pipolo R. Carrizzo A. Greco S. Voellenkle C. Vecchione C. The expression of the BPIFB4 and CXCR4 associates with sustained health in long-living individuals from Cilento-Italy Aging 2017 9 370 380 10.18632/aging.101159 28121621
219. Moll N.M. Ransohoff R.M. CXCL12 and CXCR4 in bone marrow physiology Expert Rev. Hematol. 2010 3 315 322 10.1586/ehm.10.16 21082982
220. Zlotnik A. New insights on the role of CXCR4 in cancer metastasis J. Pathol. A J. Pathol. Soc. Great Br. Irel. 2008 215 211 213 10.1002/path.2350
221. Tissenbaum H.A. Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans Nature 2001 410 227 230 10.1038/35065638 11242085
222. Whitaker R. Faulkner S. Miyokawa R. Burhenn L. Henriksen M. Wood J.G. Helfand S.L. Increased expression of Drosophila Sir 2 extends life span in a dose-dependent manner Aging 2013 5 682 691 10.18632/aging.100599 24036492
223. Hoffmann J. Romey R. Fink C. Yong L. Roeder T. Overexpression of Sir2 in the adult fat body is sufficient to extend lifespan of male and female Drosophila Aging 2013 5 315 327 10.18632/aging.100553 23765091
224. Turdi S. Li Q. Lopez F.L. Ren J. Catalase alleviates cardiomyocyte dysfunction in diabetes: Role of Akt, Forkhead transcriptional factor and silent information regulator 2 Life Sci. 2007 81 895 905 10.1016/j.lfs.2007.07.029 17765928
225. Hattori Y. Okamoto Y. Maki T. Yamamoto Y. Oishi N. Yamahara K. Nagatsuka K. Takahashi R. Kalaria R.N. Fukuyama H. Silent Information Regulator 2 Homolog 1 Counters Cerebral Hypoperfusion Injury by Deacetylating Endothelial Nitric Oxide Synthase Stroke 2014 45 3403 3411 10.1161/STROKEAHA.114.006265 25213338
226. Yoon D.S. Cha D.S. Choi Y. Lee J.W. Lee M.H. MPK-1/ERK is required for the full activity of resveratrol in extended lifespan and reproduction Aging Cell 2019 18 e12867 10.1111/acel.12867 30575269
227. Chung E. Kondo M. Role of Ras/Raf/MEK/ERK signaling in physiological hematopoiesis and leukemia development Immunol. Res. 2010 49 248 268 10.1007/s12026-010-8187-5
228. Kim H. Wu X. Lee J. SLC31 (CTR) family of copper transporters in health and disease Mol. Asp. Med. 2013 34 561 570 10.1016/j.mam.2012.07.011
229. Mahley R.W. Rall S.C. Jr. Apolipoprotein E: Far more than a lipid transport protein Annu. Rev. Genom. Hum. Genet. 2000 1 507 537 10.1146/annurev.genom.1.1.507
230. Fullerton S.M. Clark A. Weiss K.M. Nickerson D.A. Taylor S.L. Stengård J.H. Salomaa V. Vartiainen E. Perola M. Boerwinkle E. Apolipoprotein E Variation at the Sequence Haplotype Level: Implications for the Origin and Maintenance of a Major Human Polymorphism Am. J. Hum. Genet. 2000 67 881 900 10.1086/303070 10986041
231. Stengård J.H. Clark A. Weiss K.M. Kardia S. Nickerson D.A. Salomaa V. Ehnholm C. Boerwinkle E. Sing C.F. Contributions of 18 Additional DNA Sequence Variations in the Gene Encoding Apolipoprotein E to Explaining Variation in Quantitative Measures of Lipid Metabolism Am. J. Hum. Genet. 2002 71 501 517 10.1086/342217 12165926
232. Swertfeger D. Hui D.Y. Apolipoprotein E Receptor Binding VersusHeparan Sulfate Proteoglycan Binding in Its Regulation of Smooth Muscle Cell Migration and Proliferation J. Biol. Chem. 2001 276 25043 25048 10.1074/jbc.M102357200 11350966
233. Tudorache I.F. Trusca V.G. Gafencu A.V. Apolipoprotein E-a multifunctional protein with implications in various pathol-ogies as a result of its structural features Comput. Struct. Biotechnol. J. 2017 15 359 365 10.1016/j.csbj.2017.05.003 28660014
234. Gerdes L.U. Gerdes C. Hansen P.S. Klausen I.C. Faergeman O. Dyerberg J. The apolipoprotein E polymorphism in Greenland Inuit in its global perspective Qual. Life Res. 1996 98 546 550 10.1007/s004390050257 8882873
235. Ewbank D.C. The APOE gene and differences in life expectancy in Europe J. Gerontol. Ser. A Biol. Sci. Med. Sci. 2004 59 B16 B20 10.1093/gerona/59.1.B16
236. Song Y. Stampfer M.J. Liu S. Meta-Analysis: Apolipoprotein E Genotypes and Risk for Coronary Heart Disease Ann. Intern. Med. 2004 141 137 147 10.7326/0003-4819-141-2-200407200-00013 15262670
237. Bertram L. McQueen M.B. Mullin K. Blacker D. Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic asso-ciation studies: The AlzGene database Nat. Genet. 2007 39 17 23 10.1038/ng1934 17192785
238. Kulminski A.M. Arbeev K.G. Culminskaya I. Arbeeva L. Ukraintseva S.V. Stallard E. Christensen K. Schupf N. Province M.A. Yashin A.I. Age, Gender, and Cancer but Not Neurodegenerative and Cardiovascular Diseases Strongly Modulate Systemic Effect of the Apolipoprotein E4 Allele on Lifespan PLoS Genet. 2014 10 e1004141 10.1371/journal.pgen.1004141 24497847
239. Finch C.E. Evolution of the human lifespan and diseases of aging: Roles of infection, inflammation, and nutrition Proc. Natl. Acad. Sci. USA 2009 107 1718 1724 10.1073/pnas.0909606106 19966301
240. Finch C.E. Evolution of the human lifespan, past, present, and future: Phases in the evolution of human life expectancy in relation to the inflammatory load Proc. Am. Philos. Soc. USA 2012 156 9 44
241. Finch C.E. Stanford C.B. Meat-Adaptive Genes and the Evolution of Slower Aging in Humans Q. Rev. Biol. 2004 79 3 50 10.1086/381662 15101252
242. Raichlen D.A. Alexander G.E. Exercise, APOE genotype, and the evolution of the human lifespan Trends Neurosci. 2014 37 247 255 10.1016/j.tins.2014.03.001 24690272
243. Shinohara M. Suzuki K. Bu G. Sato N. Interaction Between APOE Genotype and Diabetes in Longevity J. Alzheimer’s Dis. 2021 82 719 726 10.3233/JAD-210125 34092638
244. Hawkes K. O’Connell J.F. How old is human longevity? J. Hum. Evol. 2005 49 650 653 10.1016/j.jhevol.2005.04.012 16226787
245. Makkar S.R. Lipnicki D.M. Crawford J.D. Kochan N.A. Castro-Costa E. Lima-Costa M.F. Diniz B.S. Brayne C. Stephan B. Matthews F. APOE ε4 and the Influence of Sex, Age, Vascular Risk Factors, and Ethnicity on Cognitive Decline J. Gerontol. Ser. A Boil. Sci. Med Sci. 2020 75 1863 1873 10.1093/gerona/glaa116 32396611
246. Sasaki T. Nishimoto Y. Abe Y. Takayama M. Hirose N. Okano H. Arai Y. Sex-Specific Effects of Apolipoprotein ε4 Allele on Mortality in Very Old and Centenarian Japanese Men J. Gerontol. Ser. A Boil. Sci. Med Sci. 2019 75 1874 1879 10.1093/gerona/glz242 31603980
247. Dhillon V.S. Deo P. Chua A. Thomas P. Fenech M. Shorter telomere length in carriers of APOE-ε4 and high plasma concentration of glucose, glyoxal and other advanced glycation end products (AGEs) J. Gerontol. Ser. A 2020 75 1894 1898 10.1093/gerona/glz203 31541246
248. Garatachea N. Emanuele E. Calero M. Fuku N. Arai Y. Abe Y. Murakami H. Miyachi M. Yvert T. Verde Z. ApoE gene and exceptional longevity: Insights from three independent cohorts Exp. Gerontol. 2014 53 16 23 10.1016/j.exger.2014.02.004 24534555
249. Bourdon J.-C. p53 and its isoforms in cancer Br. J. Cancer 2007 97 277 282 10.1038/sj.bjc.6603886 17637683
250. Levine A.J. p53: 800 million years of evolution and 40 years of discovery Nat. Cancer 2020 20 471 480 10.1038/s41568-020-0262-1
251. Hu W. Feng Z. Teresky A.K. Levine A.J. p53 regulates maternal reproduction through LIF Nature 2007 450 721 724 10.1038/nature05993 18046411
252. Levine A.J. Tomasini R. McKeon F.D. Mak T.W. Melino G. The p53 family: Guardians of maternal reproduction Nat. Rev. Mol. Cell Biol. 2011 12 259 265 10.1038/nrm3086 21427767
253. van Heemst D. Mooijaart S. Beekman M. Schreuder J. de Craen A.J. Brandt B.W. Slagboom P. Westendorp R.G. Variation in the human TP53 gene affects old age survival and cancer mortality Exp. Gerontol. 2004 40 11 15 10.1016/j.exger.2004.10.001 15732191
254. Ørsted D.D. Bojesen S.E. Tybjærg-Hansen A. Nordestgaard B.G. Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population J. Cell Biol. 2007 177 i14 10.1083/JCB1775OIA14
255. Boyd-Kirkup J.D. Green C.D. Wu G. Wang D. Han J.D. Epigenomics and the regulation of aging Epigenomics 2013 5 205 227 10.2217/epi.13.5 23566097
256. Maier B. Gluba W. Bernier B. Turner T. Mohammad K. Guise T. Sutherland A. Thorner M. Scrable H. Modulation of mammalian life span by the short isoform of p53 Genes Dev. 2004 18 306 319 10.1101/gad.1162404 14871929
257. Sulak M. Fong L. Mika K. Chigurupati S. Yon L. Mongan N. Emes R. Lynch V.J. Correction: TP53 copy number expansion is associated with the evolution of increased body size and an enhanced DNA damage response in elephants eLife 2016 5 e11994 10.7554/eLife.11994 27642012
258. Lee S.-H. Lee J.-H. Lee H.-Y. Min A.K.-J. Sirtuin signaling in cellular senescence and aging BMB Rep. 2019 52 24 34 10.5483/BMBRep.2019.52.1.290 30526767
259. Yoshizaki T. Schenk S. Imamura T. Babendure J.L. Sonoda N. Bae E.J. Oh D.Y. Lu M. Milne J.C. Westphal C. SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity Am. J. Physiol. Metab. 2010 298 E419 E428 10.1152/ajpendo.00417.2009
260. Yeung F. Hoberg J.E. Ramsey C.S. Keller M.D. Jones D.R. Frye R.A. Mayo M.W. Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase EMBO J. 2004 23 2369 2380 10.1038/sj.emboj.7600244 15152190
261. Cohen H.Y. Miller C. Bitterman K.J. Wall N.R. Hekking B. Kessler B. Howitz K.T. Gorospe M. de Cabo R. Sinclair D.A. Calorie Restriction Promotes Mammalian Cell Survival by Inducing the SIRT1 Deacetylase Science 2004 305 390 392 10.1126/science.1099196 15205477
262. Wang Y. He J. Liao M. Hu M. Li W. Ouyang H. Wang X. Ye T. Zhang Y. Ouyang L. An overview of Sirtuins as potential therapeutic target: Structure, function and modulators Eur. J. Med. Chem. 2018 161 48 77 10.1016/j.ejmech.2018.10.028 30342425
263. Bernier M. Paul R.K. Martin-Montalvo A. Scheibye-Knudsen M. Song S. He H.-J. Armour S.M. Hubbard B. Bohr V.A. Wang L. Negative Regulation of STAT3 Protein-mediated Cellular Respiration by SIRT1 Protein J. Biol. Chem. 2011 286 19270 19279 10.1074/jbc.M110.200311 21467030
264. Brunet A. Sweeney L.B. Sturgill J.F. Chua K.F. Greer P.L. Lin Y. Tran H. Ross S.E. Mostoslavsky R. Cohen H.Y. Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 Deacetylase Science 2004 303 2011 2015 10.1126/science.1094637 14976264
265. Rogina B. Helfand S.L. Sir2 mediates longevity in the fly through a pathway related to calorie restriction Proc. Natl. Acad. Sci. USA 2004 101 15998 16003 10.1073/pnas.0404184101 15520384
266. Kanfi Y. Naiman S. Amir G. Peshti V. Zinman G. Nahum L. Bar-Joseph Z. Cohen H.Y. The sirtuin SIRT6 regulates lifespan in male mice Nature 2012 483 218 221 10.1038/nature10815 22367546
267. Satoh A. Brace C.S. Rensing N. Cliften P. Wozniak D.F. Herzog E. Yamada K.A. Imai S.-I. Sirt1 Extends Life Span and Delays Aging in Mice through the Regulation of Nk2 Homeobox 1 in the DMH and LH Cell Metab. 2013 18 416 430 10.1016/j.cmet.2013.07.013 24011076
268. Canto C. Houtkooper R.H. Pirinen E. Youn D.Y. Oosterveer M.H. Cen Y. Fernandez-Marcos P.J. Yamamoto H. Andreux P.A. Cettour-Rose P. The NAD+ Precursor Nicotinamide Riboside Enhances Oxidative Metabolism and Protects against High-Fat Diet-Induced Obesity Cell Metab. 2012 15 838 847 10.1016/j.cmet.2012.04.022 22682224
269. Mills K.F. Yoshida S. Stein L.R. Grozio A. Kubota S. Sasaki Y. Redpath P. Migaud M.E. Apte R.S. Uchida K. Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice Cell Metab. 2016 24 795 806 10.1016/j.cmet.2016.09.013 28068222
270. Guan Y. Wang S.R. Huang X.Z. Xie Q.H. Xu Y.Y. Shang D. Hao C.M. Nicotinamide Mononucleotide, an NAD+ Precursor, Rescues Age-Associated Susceptibility to AKI in a Sirtuin 1–Dependent Manner J. Am. Soc. Nephrol. 2017 28 2337 2352 10.1681/ASN.2016040385 28246130
271. Amano H. Chaudhury A. Rodriguez-Aguayo C. Lu L. Akhanov V. Catic A. Popov Y.V. Verdin E. Johnson H. Stossi F. Telomere Dysfunction Induces Sirtuin Repression that Drives Telomere-Dependent Disease Cell Metab. 2019 29 1274 1290.e9 10.1016/j.cmet.2019.03.001 30930169
272. Pi C. Yang Y. Sun Y. Wang H. Sun H. Ma M. Lin L. Shi Y. Li Y. Li Y. Nicotinamide phosphoribosyltransferase postpones rat bone marrow mesenchymal stem cell senescence by mediating NAD+–Sirt1 signaling Aging 2019 11 3505 3522 10.18632/aging.101993 31175267
273. Mendelsohn A.R. Larrick J.W. The NAD+/PARP1/SIRT1 Axis in Aging Rejuvenation Res. 2017 20 244 247 10.1089/rej.2017.1980 28537485
274. Liang F. Chen R. Nakagawa A. Nishizawa M. Tsuda S. Wang H. Koya D. Low-Frequency Electroacupuncture Improves Insulin Sensitivity in Obese Diabetic Mice through Activation of SIRT1/PGC-1αin Skeletal Muscle Evid.-Based Complement. Altern. Med. 2011 2011 735297 10.1155/2011/735297 20981161
275. Kim M.J. An H.J. Kim D.H. Lee B. Lee H.J. Ullah S. Kim S.J. Jeong H.O. Moon K.M. Lee E.K. Novel SIRT1 activator MHY2233 improves glucose tolerance and reduces hepatic lipid accumulation in db/db mice Bioorgan. Med. Chem. Lett. 2018 28 684 688 10.1016/j.bmcl.2018.01.021
276. Yoshizaki T. Milne J.C. Imamura T. Schenk S. Sonoda N. Babendure J.L. Lu J.-C. Smith J.J. Jirousek M.R. Olefsky J.M. SIRT1 Exerts Anti-Inflammatory Effects and Improves Insulin Sensitivity in Adipocytes Mol. Cell. Biol. 2009 29 1363 1374 10.1128/MCB.00705-08 19103747
277. Cheng Y.-Y. Kao C.-L. Ma H.-I. Hung C.-H. Wang C.-T. Liu D.-H. Chen P.-Y. Tsai K.-L. SIRT1-related inhibition of pro-inflammatory responses and oxidative stress are involved in the mechanism of nonspecific low back pain relief after exercise through modulation of Toll-like receptor 4 J. Biochem. 2015 158 299 308 10.1093/jb/mvv041 25922201
278. Xu F. Xu J. Xiong X. Deng Y. Salidroside inhibits MAPK, NF-κB, and STAT3 pathways in psoriasis-associated oxidative stress via SIRT1 activation Redox Rep. 2019 24 70 74 10.1080/13510002.2019.1658377 31495284
279. Hori Y.S. Kuno A. Hosoda R. Horio Y. Regulation of FOXOs and p53 by SIRT1 Modulators under Oxidative Stress PLoS ONE 2013 8 e73875 10.1371/journal.pone.0073875 24040102
280. Yao H. Yao Z. Zhang S. Zhang W. Zhou W. Upregulation of SIRT1 inhibits H2O2-induced osteoblast apoptosis via FoxO1/β-catenin pathway Mol. Med. Rep. 2018 17 6681 6690 10.3892/mmr.2018.8657 29512706
281. Yu X. Zhang S. Zhao D. Zhang X. Xia C. Wang T. Zhang M. Liu T. Huang W. Wu B. SIRT1 inhibits apoptosis in in vivo and in vitro models of spinal cord injury via microRNA-494 Int. J. Mol. Med. 2019 43 1758 1768 10.3892/ijmm.2019.4106 30816451
282. Ren R. Wang Z. Wu M. Wang H. Emerging Roles of SIRT1 in Alcoholic Liver Disease Int. J. Biol. Sci. 2020 16 3174 3183 10.7150/ijbs.49535 33162823
283. Yu M. Zhang H. Wang B. Zhang Y. Zheng X. Shao B. Zhuge Q. Jin K. Key Signaling Pathways in Aging and Potential Interventions for Healthy Aging Cells 2021 10 660 10.3390/cells10030660 33809718
284. Warner H.R. The Future of Aging Interventions: Current Status of Efforts to Measure and Modulate the Biological Rate of Aging J. Gerontol. Ser. A Boil. Sci. Med Sci. 2004 59 B692 B696 10.1093/gerona/59.7.B692 15304533
285. Jylhävä J. Pedersen N.L. Hägg S. Biological Age Predictors eBioMedicine 2017 21 29 36 10.1016/j.ebiom.2017.03.046 28396265
286. Hannum G. Guinney J. Zhao L. Zhang L. Hughes G. Sadda S. Klotzle B. Bibikova M. Fan J.-B. Gao Y. Genome-wide Methylation Profiles Reveal Quantitative Views of Human Aging Rates Mol. Cell 2012 49 359 367 10.1016/j.molcel.2012.10.016 23177740
287. Horvath S. DNA methylation age of human tissues and cell types Genome Biol. 2013 14 R115 10.1186/gb-2013-14-10-r115 24138928
288. Levine M.E. Lu A.T. Quach A. Chen B.H. Assimes T.L. Bandinelli S. Hou L. Baccarelli A.A. Stewart J.D. Li Y. An epigenetic biomarker of aging for lifespan and healthspan Aging 2018 10 573 591 10.18632/aging.101414 29676998
289. Lu A.T. Quach A. Wilson J.G. Reiner A.P. Aviv A. Raj K. Hou L. Baccarelli A.A. Li Y. Stewart J.D. DNA methylation GrimAge strongly predicts lifespan and healthspan Aging 2019 11 303 327 10.18632/aging.101684 30669119
290. Fransquet P.D. Wrigglesworth J. Woods R.L. Ernst M.E. Ryan J. The epigenetic clock as a predictor of disease and mortality risk: A systematic review and meta-analysis Clin. Epigenet. 2019 11 62 10.1186/s13148-019-0656-7
291. Dugué P.-A. Bassett J.K. Joo J.E. Jung C.-H. Wong E.M. Moreno-Betancur M. Schmidt D. Makalic E. Li S. Severi G. DNA methylation-based biological aging and cancer risk and survival: Pooled analysis of seven prospective studies Int. J. Cancer 2017 142 1611 1619 10.1002/ijc.31189 29197076
292. Zheng C. Li L. Xu R. Association of Epigenetic Clock with Consensus Molecular Subtypes and Overall Survival of Colorectal Cancer Cancer Epidemiol. Biomark. Prev. 2019 28 1720 1724 10.1158/1055-9965.EPI-19-0208
293. Ni Z. Ebata A. Alipanahiramandi E. Lee S.S. Two SET domain containing genes link epigenetic changes and aging in Caenorhabditis elegans Aging Cell 2011 11 315 325 10.1111/j.1474-9726.2011.00785.x 22212395
294. Greer E.L. Maures T.J. Hauswirth A.G. Green E.M. Leeman D.S. Maro G.S. Han S. Banko M.R. Gozani O. Brunet A. Members of the H3K4 trimethylation complex regulate lifespan in a germline-dependent manner in C. elegans Nature 2010 466 383 387 10.1038/nature09195 20555324
295. Lionaki E. Markaki M. Tavernarakis N. Autophagy and ageing: Insights from invertebrate model organisms Ageing Res. Rev. 2013 12 413 428 10.1016/j.arr.2012.05.001 22634332
296. Wysocki R. Javaheri A. Allard S. Sha F. Cote J. Kron S.J. Role of Dot1-Dependent Histone H3 Methylation in G 1 and S Phase DNA Damage Checkpoint Functions of Rad9 Mol. Cell. Biol. 2005 25 8430 8443 10.1128/MCB.25.19.8430-8443.2005 16166626
297. Kouzarides T. Chromatin modifications and their function Cell 2007 128 693 705 10.1016/j.cell.2007.02.005 17320507
298. Wang Z.C.A. Choate L.A. Rice E.J. Miller D.C. Chu T. Chou S.P. Kingsley N.B. Petersen J.L. Finno C.J. Bellone R.R. Accurate imputation of histone modifications using transcription bioRxiv 2020 10.1101/2020.04.08.032730
299. Downey M. Baetz K. Building a KATalogue of acetyllysine targeting and function Brief. Funct. Genom. 2015 15 109 118 10.1093/bfgp/elv045
300. Benayoun B. Pollina E.A. Brunet A. Epigenetic regulation of ageing: Linking environmental inputs to genomic stability Nat. Rev. Mol. Cell Biol. 2015 16 593 610 10.1038/nrm4048 26373265
301. Peleg S. Feller C. Ladurner A. Imhof A. The Metabolic Impact on Histone Acetylation and Transcription in Ageing Trends Biochem. Sci. 2016 41 700 711 10.1016/j.tibs.2016.05.008 27283514
302. Soukas A.A. Hao H. Wu L. Metformin as Anti-Aging Therapy: Is It for Everyone? Trends Endocrinol. Metab. 2019 30 745 755 10.1016/j.tem.2019.07.015 31405774
303. DiMauro T. Ras-Induced Senescence and its Physiological Relevance in Cancer Curr. Cancer Drug Targets 2010 10 869 876 10.2174/156800910793357998 20718709
304. Li Y. Tollefsbol T.O. p16INK4a Suppression by Glucose Restriction Contributes to Human Cellular Lifespan Extension through SIRT1-Mediated Epigenetic and Genetic Mechanisms PLoS ONE 2011 6 e17421 10.1371/journal.pone.0017421 21390332
305. Everitt A.V. Le Couteur D. Life Extension by Calorie Restriction in Humans Ann. N. Y. Acad. Sci. 2007 1114 428 433 10.1196/annals.1396.005 17717102
306. Giacomello E. Toniolo L. The Potential of Calorie Restriction and Calorie Restriction Mimetics in Delaying Aging: Focus on Experimental Models Nutrients 2021 13 2346 10.3390/nu13072346 34371855
307. Freitas A. de Magalhaes J.P. A review and appraisal of the DNA damage theory of ageing Mutat. Res. Mutat. Res. 2011 728 12 22 10.1016/j.mrrev.2011.05.001 21600302
308. Roca-Bayerri C. Robertson F. Pyle A. Hudson G. Payne B.A.I. Mitochondrial DNA Damage and Brain Aging in Human Immunodeficiency Virus Clin. Infect. Dis. 2020 73 e466 e473 10.1093/cid/ciaa984
309. Vijg J. From DNA damage to mutations: All roads lead to aging Ageing Res. Rev. 2021 68 101316 10.1016/j.arr.2021.101316 33711511
310. Oberdoerffer P. Michan S. McVay M. Mostoslavsky R. Vann J. Park S.-K. Hartlerode A. Stegmuller J. Hafner A. Loerch P. SIRT1 Redistribution on Chromatin Promotes Genomic Stability but Alters Gene Expression during Aging Cell 2008 135 907 918 10.1016/j.cell.2008.10.025 19041753
311. Kajitani G.S. Nascimento L.L.D.S. Neves M.R.D.C. Leandro G.D.S. Garcia C.C.M. Menck C.F.M. Transcription blockage by DNA damage in nucleotide excision repair-related neurological dysfunctions Semin. Cell Dev. Biol. 2020 114 20 35 10.1016/j.semcdb.2020.10.009 33229217
312. Roos W.P. Kaina B. DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosis Cancer Lett. 2013 332 237 248 10.1016/j.canlet.2012.01.007 22261329
313. Cheng C.-H. Ma H.-L. Deng Y.-Q. Feng J. Jie Y.-K. Guo Z.-X. Oxidative stress, cell cycle arrest, DNA damage and apoptosis in the mud crab (Scylla paramamosain) induced by cadmium exposure Chemosphere 2020 263 128277 10.1016/j.chemosphere.2020.128277 33297221
314. Sadoughi F. Hallajzadeh J. Asemi Z. Mansournia M.A. Alemi F. Yousefi B. Signaling pathways involved in cell cycle arrest during the DNA breaks DNA Repair 2021 98 103047 10.1016/j.dnarep.2021.103047 33454524
315. Jansma M. Hopfner K.-P. Structural basis of the (in)activity of the apical DNA damage response kinases ATM, ATR and DNA-PKcs Prog. Biophys. Mol. Biol. 2020 163 120 129 10.1016/j.pbiomolbio.2020.10.009 33166573
316. Williams R.M. Zhang X. Roles of ATM and ATR in DNA double strand breaks and replication stress Prog. Biophys. Mol. Biol. 2020 161 27 38 10.1016/j.pbiomolbio.2020.11.005 33259832
317. Shibata A. Jeggo P.A. ATM’s Role in the Repair of DNA Double-Strand Breaks Genes 2021 12 1370 10.3390/genes12091370 34573351
318. Eliezer Y. Argaman L. Rhie A. Doherty A.J. Goldberg M. The Direct Interaction between 53BP1 and MDC1 Is Required for the Recruitment of 53BP1 to Sites of Damage J. Biol. Chem. 2009 284 426 435 10.1074/jbc.M807375200 18986980
319. Day M. Oliver A.W. Pearl L.H. Phosphorylation-dependent assembly of DNA damage response systems and the central roles of TOPBP1 DNA Repair 2021 108 103232 10.1016/j.dnarep.2021.103232 34678589
320. Bagge J. Oestergaard V.H. Lisby M. Functions of TopBP1 in preserving genome integrity during mitosis Semin. Cell Dev. Biol. 2020 113 57 64 10.1016/j.semcdb.2020.08.009 32912640
321. Shieh S.Y. Ahn J. Tamai K. Taya Y. Prives C. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phos-phorylate p53 at multiple DNA damage-inducible sites Genes Dev. 2000 14 289 300 10.1101/gad.14.3.289 10673501
322. Jiang S. Deng N. Zheng B. Li T. Liu R.H. Rhodiola extract promotes longevity and stress resistance of Caenorhabditis elegans via DAF-16 and SKN-1 Food Funct. 2021 12 4471 4483 10.1039/D0FO02974B 33881421
323. Geden M.J. Romero S.E. Deshmukh M. p53 is required for nuclear but not mitochondrial DNA damage-induced degeneration Cell Death Dis. 2021 12 104 10.1038/s41419-020-03373-1 33473103
324. Liu D. Xu Y. p53, oxidative stress, and aging Antioxid. Redox Signal. 2011 15 1669 1678 10.1089/ars.2010.3644 21050134
325. Kawanishi S. Hiraku Y. Oikawa S. Mechanism of guanine-specific DNA damage by oxidative stress and its role in carcinogenesis and aging Mutat. Res. Mutat. Res. 2001 488 65 76 10.1016/S1383-5742(00)00059-4 11223405
326. Valdiglesias V. Bonassi S. Dell’Armi V. Settanni S. Celi M. Mastropaolo S. Antocicco M. Fini M. Onder G. Micronucleus frequency in peripheral blood lymphocytes and frailty status in elderly. A lack of association with clinical features Mutat. Res. Mol. Mech. Mutagen. 2015 780 47 54 10.1016/j.mrfmmm.2015.07.010
327. Thomas P. Fenech M. A review of genome mutation and Alzheimer’s disease Mutagenesis 2006 22 15 33 10.1093/mutage/gel055 17158517
328. Coppedè F. Migliore L. DNA repair in premature aging disorders and neurodegeneration Curr. Aging Sci. 2010 3 3 19 10.2174/1874609811003010003 20298165
329. Migliore L. Coppedè F. Fenech M. Thomas P. Association of micronucleus frequency with neurodegenerative diseases Mutagenesis 2010 26 85 92 10.1093/mutage/geq067
330. Weng N.-P. Aging of the Immune System: How Much Can the Adaptive Immune System Adapt? Immunity 2006 24 495 499 10.1016/j.immuni.2006.05.001 16713964
331. Reed J.R. Vukmanovic-Stejic M. Fletcher J.M. Soares M.V.D. Cook J.E. Orteu C.H. Jackson S.E. Birch K.E. Foster G.R. Salmon M. Telomere Erosion in Memory T Cells Induced by Telomerase Inhibition at the Site of Antigenic Challenge In Vivo J. Exp. Med. 2004 199 1433 1443 10.1084/jem.20040178 15148341
332. Liu F. Chang H.-C. Physiological links of circadian clock and biological clock of aging Protein Cell 2017 8 477 488 10.1007/s13238-016-0366-2 28108951
333. Kucia M. Ratajczak M.Z. Plausible Links Between Metabolic Networks, Stem Cells, and Longevity Stem Cells 2019 1201 355 388 10.1007/978-3-030-31206-0_15
334. Li Y. Ma Z. Jiang S. Hu W. Li T. Di S. Wang D. Yang Y. A global perspective on FOXO1 in lipid metabolism and lipid-related diseases Prog. Lipid Res. 2017 66 42 49 10.1016/j.plipres.2017.04.002 28392404
335. Graves D.T. Milovanova T.N. Mucosal Immunity and the FOXO1 Transcription Factors Front. Immunol. 2019 10 2530 10.3389/fimmu.2019.02530 31849924
336. Delpoux A. Marcel N. Michelini R.H. Katayama C.D. Allison K.A. Glass C.K. Quiñones-Parra S.M. Murre C. Loh L. Kedzierska K. FOXO1 constrains activation and regulates senescence in CD8 T cells Cell Rep. 2021 34 108674 10.1016/j.celrep.2020.108674 33503413
337. Hannenhalli S. Kaestner K.H. The evolution of Fox genes and their role in development and disease Nat. Rev. Genet. 2009 10 233 240 10.1038/nrg2523 19274050
338. Zečić A. Braeckman B.P. DAF-16/FoxO in Caenorhabditis elegans and Its Role in Metabolic Remodeling Cells 2020 9 109 10.3390/cells9010109
339. Menu E. Jernberg-Wiklund H. Stromberg T. De Raeve H. Girnita L. Larsson O. Axelson M. Asosingh K. Nilsson K. Van Camp B. Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: An in vitro and in vivo study in the 5T33MM mouse model Blood 2006 107 655 660 10.1182/blood-2005-01-0293 16046527
340. Zemva J. Schubert M. The role of neuronal insulin/insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer’s disease: Possible therapeutic implications CNS Neurol. Disord. Drug Targets 2014 13 322 337 10.2174/18715273113126660141 24059318
341. Libina N. Berman J.R. Kenyon C. Tissue-Specific Activities of C. elegans DAF-16 in the Regulation of Lifespan Cell 2003 115 489 502 10.1016/S0092-8674(03)00889-4 14622602
342. Dimov I. Maduro M.F. The C. elegans intestine: Organogenesis, digestion, and physiology Cell Tissue Res. 2019 377 383 396 10.1007/s00441-019-03036-4 31065800
343. Lin X.-X. Sen I. Janssens G.E. Zhou X. Fonslow B.R. Edgar D. Stroustrup N. Swoboda P. Yates J.R. Ruvkun G. DAF-16/FOXO and HLH-30/TFEB function as combinatorial transcription factors to promote stress resistance and longevity Nat. Commun. 2018 9 4400 10.1038/s41467-018-06624-0 30353013
344. Sen I. Zhou X. Chernobrovkin A. Puerta-Cavanzo N. Kanno T. Salignon J. Stoehr A. Lin X.-X. Baskaner B. Brandenburg S. DAF-16/FOXO requires Protein Phosphatase 4 to initiate transcription of stress resistance and longevity promoting genes Nat. Commun. 2020 11 138 10.1038/s41467-019-13931-7 31919361
345. Schuster E. McElwee J.J. Tullet J. Doonan R. Matthijssens F. Reece-Hoyes J.S. Hope I. Vanfleteren J.R. Thornton J. Gems D. DamID in C. elegans reveals longevity-associated targets of DAF-16/FoxO Mol. Syst. Biol. 2010 6 399 10.1038/msb.2010.54 20706209
346. Deng J. Dai Y. Tang H. Pang S. SKN-1 Is a Negative Regulator of DAF-16 and Somatic Stress Resistance in Caenorhabditis elegans G3: Genes Genomes Genet. 2020 10 1707 1712 10.1534/g3.120.401203 32161088
347. Li W.-J. Wang C.-W. Tao L. Yan Y.-H. Zhang M.-J. Liu Z.-X. Li Y.-X. Zhao H.-Q. Li X.-M. He X.-D. Insulin signaling regulates longevity through protein phosphorylation in Caenorhabditis elegans Nat. Commun. 2021 12 4568 10.1038/s41467-021-24816-z 34315882
348. Zhang C. Seong K.M. Sun W. Mittapalli O. Qiu B. Clark J.M. Pittendrigh B.R. The insulin signaling pathway in Drosophila melanogaster: A nexus revealing an “Achilles’ heel” in DDT resistance Pestic. Biochem. Physiol. 2020 171 104727 10.1016/j.pestbp.2020.104727 33357549
349. Saxton R.A. Sabatini D.M. mTOR Signaling in Growth, Metabolism, and Disease Cell 2017 168 960 976 Erratum in Cell 2017, 169, 361–371 10.1016/j.cell.2017.02.004 28283069
350. Burkart G.M. Brandizzi F. A Tour of TOR Complex Signaling in Plants Trends Biochem. Sci. 2020 46 417 428 10.1016/j.tibs.2020.11.004 33309324
351. Wu Y. Shi L. Li L. Fu L. Liu Y. Xiong Y. Sheen J. Integration of nutrient, energy, light, and hormone signalling via TOR in plants J. Exp. Bot. 2019 70 2227 2238 10.1093/jxb/erz028 30715492
352. Beauchamp E.M. Platanias L.C. The evolution of the TOR pathway and its role in cancer Oncogene 2012 32 3923 3932 10.1038/onc.2012.567 23246968
353. Lushchak O. Strilbytska O. Piskovatska V. Storey K.B. Koliada A. Vaiserman A. The role of the TOR pathway in mediating the link between nutrition and longevity Mech. Ageing Dev. 2017 164 127 138 10.1016/j.mad.2017.03.005 28315697
354. Daneshgar N. Rabinovitch P. Dai D.-F. TOR Signaling Pathway in Cardiac Aging and Heart Failure Biomolecules 2021 11 168 10.3390/biom11020168 33513917
355. Díaz-Troya S. Pérez-Pérez M.E. Pérez-Martín M. Moes S. Jeno P. Florencio F.J. Crespo J.L. Inhibition of Protein Synthesis by TOR Inactivation Revealed a Conserved Regulatory Mechanism of the BiP Chaperone in Chlamydomonas Plant Physiol. 2011 157 730 741 10.1104/pp.111.179861 21825107
356. Suginohara T. Wakabayashi K. Ato S. Ogasawara R. Effect of 2-deoxyglucose-mediated inhibition of glycolysis on the regulation of mTOR signaling and protein synthesis before and after high-intensity muscle contraction Metabolism 2020 114 154419 10.1016/j.metabol.2020.154419 33161019
357. Wu G. Yan Q. Jones J.A. Tang Y.J. Fong S.S. Koffas M.A. Metabolic Burden: Cornerstones in Synthetic Biology and Metabolic Engineering Applications Trends Biotechnol. 2016 34 652 664 10.1016/j.tibtech.2016.02.010 26996613
358. Yee Z. Lim S.H.Y. Ng L.F. Gruber J. Inhibition of mTOR decreases insoluble proteins burden by reducing translation in C. elegans Biogerontology 2020 22 101 118 10.1007/s10522-020-09906-7 33159806
359. Kenyon C.J. The genetics of ageing Nature 2010 464 504 512 10.1038/nature08980 20336132
360. Robida-Stubbs S. Glover-Cutter K. Lamming D.W. Mizunuma M. Narasimhan S.D. Neumann-Haefelin E. Sabatini D.M. Blackwell T.K. TOR Signaling and Rapamycin Influence Longevity by Regulating SKN-1/Nrf and DAF-16/FoxO Cell Metab. 2012 15 713 724 10.1016/j.cmet.2012.04.007 22560223
361. Niu W. Lu Z.J. Zhong M. Sarov M. Murray J.I. Brdlik C.M. Janette J. Chen C. Alves P. Preston E. Diverse transcription factor binding features revealed by genome-wide ChIP-seq in C. elegans Genome Res. 2010 21 245 254 10.1101/gr.114587.110 21177963
362. Somogyvari M. Gecse E. Sőti C. DAF-21/Hsp90 is required for C. elegans longevity by ensuring DAF-16/FOXO isoform A function Sci. Rep. 2018 8 12048 10.1038/s41598-018-30592-6 30104664
363. Oh S.W. Mukhopadhyay A. Svrzikapa N. Jiang F. Davis R.J. Tissenbaum H.A. JNK regulates lifespan in Caenorhabditis elegans by modulating nuclear translocation of forkhead transcription factor/DAF-16 Proc. Natl. Acad. Sci. USA 2005 102 4494 4499 10.1073/pnas.0500749102 15767565
364. Zhang R. Zhang H. Lin Y. Li J. Pober J.S. Min W. RIP1-mediated AIP1 Phosphorylation at a 14-3-3-binding Site Is Critical for Tumor Necrosis Factor-induced ASK1-JNK/p38 Activation J. Biol. Chem. 2007 282 14788 14796 10.1074/jbc.M701148200 17389591
365. Soh R. Hardy A. Nieden N.I.Z. The FOXO signaling axis displays conjoined functions in redox homeostasis and stemness Free. Radic. Biol. Med. 2021 169 224 237 10.1016/j.freeradbiomed.2021.04.022 33878426
366. Kim A.H. Sasaki T. Chao M.V. JNK-interacting Protein 1 Promotes Akt1 Activation J. Biol. Chem. 2003 278 29830 29836 10.1074/jbc.M305349200 12783873
367. Salminen A. Kaarniranta K. Genetics vs. entropy: Longevity factors suppress the NF-κB-driven entropic aging process Ageing Res. Rev. 2010 9 298 314 10.1016/j.arr.2009.11.001 19903538
368. Paillasse M.R. de Medina P. The NR4A nuclear receptors as potential targets for anti-aging interventions Med. Hypotheses 2015 84 135 140 10.1016/j.mehy.2014.12.003 25543265
369. Argyrofthalmidou M. Spathis A.D. Maniati M. Poula A. Katsianou M.A. Sotiriou E. Manousaki M. Perier C. Papapanagiotou I. Papadopoulou-Daifoti Z. Nurr1 repression mediates cardinal features of Parkinson’s disease in α-synuclein transgenic mice Hum. Mol. Genet. 2021 30 1469 1483 10.1093/hmg/ddab118 33902111

